TW202321428A - Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element - Google Patents
Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element Download PDFInfo
- Publication number
- TW202321428A TW202321428A TW111129272A TW111129272A TW202321428A TW 202321428 A TW202321428 A TW 202321428A TW 111129272 A TW111129272 A TW 111129272A TW 111129272 A TW111129272 A TW 111129272A TW 202321428 A TW202321428 A TW 202321428A
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- group
- crystal alignment
- methyl
- alignment agent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Nonlinear Science (AREA)
- General Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mathematical Physics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Liquid Crystal (AREA)
Abstract
Description
本發明係關於液晶配向劑、由該液晶配向劑獲得之液晶配向膜、及具備該液晶配向膜之液晶顯示元件。The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film obtained from the liquid crystal alignment agent, and a liquid crystal display element equipped with the liquid crystal alignment film.
液晶顯示元件,廣泛使用在行動電話、智慧手機等小型用途到電視用、螢幕用等之較大型之用途。液晶顯示元件,一般係將一對電極基板以預定間隙(數μm)互相面對的方式配置並且於電極基板之間封入液晶而構成。並且,係藉由對於構成電極基板之各電極之透明導電膜間施加電壓,以於液晶顯示元件實施顯示。此等液晶顯示元件,具有為了控制液晶分子之排列狀態所不可欠缺的液晶配向膜。就液晶顯示元件而言,已開發出電極結構、使用之液晶分子之物性等不同的各種驅動方式。例如已知有TN(扭轉向列,Twisted Nematic)方式、STN(超級扭轉向列,Super Twisted Nematic)方式、VA(垂直排列,Vertical Alignment)方式、IPS(面內切換,In-Plane Switching)方式、FFS(邊緣場切換,Fringe Field Switching)方式等各種模式。Liquid crystal display devices are widely used in small applications such as mobile phones and smart phones, as well as larger applications such as TVs and monitors. A liquid crystal display element is generally configured by arranging a pair of electrode substrates to face each other with a predetermined gap (several μm), and sealing liquid crystal between the electrode substrates. In addition, display is performed on the liquid crystal display element by applying a voltage between the transparent conductive films constituting the electrodes of the electrode substrate. These liquid crystal display elements have a liquid crystal alignment film which is indispensable for controlling the alignment state of liquid crystal molecules. For liquid crystal display elements, various driving methods have been developed that differ in electrode structure, physical properties of liquid crystal molecules used, and the like. For example, TN (Twisted Nematic) method, STN (Super Twisted Nematic) method, VA (Vertical Alignment) method, and IPS (In-Plane Switching) method are known. , FFS (Fringe Field Switching, Fringe Field Switching) mode and other modes.
VA(垂直配向)方式之液晶顯示元件,由於視野角廣、響應速度快、對比度大,而且生產處理上亦能夠省略摩擦處理,尤其以大型化的需求高的電視用途、螢幕用途為中心而被廣泛地使用(專利文獻1~2)。就形成液晶配向膜之高分子材料而言,一般常使用聚醯亞胺系聚合物。專利文獻3中,考量提高液晶配向之安定性之觀點,揭示使用含有芳香族四羧酸二酐與芳香族二胺之單體成分獲得之聚醯亞胺系液晶配向膜。 [先前技術文獻] [專利文獻] VA (Vertical Alignment) type liquid crystal display element, because of its wide viewing angle, fast response speed, high contrast ratio, and the friction treatment can be omitted in the production process, it is especially used for large-scale TV applications and screen applications. It is widely used (Patent Documents 1 to 2). In terms of polymer materials for forming liquid crystal alignment films, polyimide polymers are generally used. Patent Document 3 discloses a polyimide-based liquid crystal alignment film obtained by using a monomer component containing aromatic tetracarboxylic dianhydride and aromatic diamine in consideration of improving the stability of liquid crystal alignment. [Prior Art Literature] [Patent Document]
[專利文獻1]日本特開2008-76950號公報 [專利文獻2]國際公開第2008/117615號 [專利文獻3]日本特開昭57-40227號公報 [Patent Document 1] Japanese Unexamined Patent Publication No. 2008-76950 [Patent Document 2] International Publication No. 2008/117615 [Patent Document 3] Japanese Patent Laid-Open No. 57-40227
(發明欲解決之課題)(Problem to be solved by the invention)
近年來已開發了4K、8K這類超高精細的面板,該等面板中,黑色矩陣(BM)、TFT等的占有率增大,面板的開口率降低,因此顯示部之透光率提升受到重視。In recent years, ultra-high-definition panels such as 4K and 8K have been developed. In these panels, the share of black matrix (BM) and TFT has increased, and the aperture ratio of the panel has decreased. Therefore, the increase in light transmittance of the display part is affected by Pay attention to.
又,液晶顯示元件若其電壓保持率(VHR:Voltage Holding Ratio)低,則即使施加電壓,仍難以對於液晶分子施加充分的電壓。所以,由於高溫高濕下之使用、長期使用等會導致顯示對比度降低,或是顯示發生(flicker)而顯示不良。尤其是車用導航系統、儀表板面板等車載用途中,有時會在長時間高溫環境下使用或放置,於此情形,電壓保持率之下降更顯著,需要有高電壓保持率之液晶配向膜。Also, if the voltage holding ratio (VHR: Voltage Holding Ratio) of the liquid crystal display element is low, it is difficult to apply a sufficient voltage to the liquid crystal molecules even if a voltage is applied. Therefore, due to use under high temperature and high humidity, long-term use, etc., the display contrast may decrease, or flicker may occur, resulting in poor display. Especially in automotive applications such as car navigation systems and instrument panel panels, sometimes they are used or placed in a high-temperature environment for a long time. In this case, the drop in voltage retention rate is more significant, and a liquid crystal alignment film with high voltage retention rate is required. .
另一方面,使用如專利文獻3之含有芳香族四羧酸二酐及芳香族二胺之單體成分獲得之所謂全芳香族聚醯亞胺,因會發生分子內或分子間電荷移動遷移(以下也將電荷移動遷移稱為CT遷移),於可見光區發生吸收,造成聚醯亞胺膜著色。由發明人的研究了解到:上述聚醯亞胺膜之著色於添加了交聯性化合物時會更劇烈。On the other hand, the use of so-called wholly aromatic polyimides obtained from monomer components containing aromatic tetracarboxylic dianhydrides and aromatic diamines such as Patent Document 3, due to intramolecular or intermolecular charge transfer ( Hereinafter, the charge transfer migration is also referred to as CT migration), which absorbs in the visible light region and causes the coloring of the polyimide film. The research of the inventors revealed that the coloring of the above-mentioned polyimide film becomes more intense when a cross-linking compound is added.
有鑑於上述情事,本發明之目的在於提供即使添加了交聯性化合物仍會形成可獲得高光透射率且具有高電壓保持率之液晶配向膜之液晶配向劑、由該液晶配向劑獲得之液晶配向膜、及具有該液晶配向膜之液晶顯示元件。 (解決課題之方式) In view of the foregoing, the object of the present invention is to provide a liquid crystal alignment agent capable of forming a liquid crystal alignment film capable of obtaining a high light transmittance and a high voltage retention even when a crosslinking compound is added, and a liquid crystal alignment obtained by the liquid crystal alignment agent. film, and a liquid crystal display element with the liquid crystal alignment film. (How to solve the problem)
本案發明人為了達成上述課題而努力研究,結果發現含有使用特定原料成分獲得之聚合物成分及特定之交聯性化合物之液晶配向劑,對於達成上述目的為有效,乃完成本發明。The inventors of the present invention worked hard to achieve the above-mentioned problems, and as a result, found that a liquid crystal alignment agent containing a polymer component obtained using a specific raw material component and a specific cross-linking compound is effective for achieving the above-mentioned object, and completed the present invention.
本發明係以含有下列(A)成分及(B)成分為特徵之液晶配向劑、由該液晶配向劑獲得之液晶配向膜、及具有該液晶配向膜之液晶顯示元件。 (A)成分:聚合物(P),係選自由含有下式(1)表示之二胺之二胺成分與含有芳香族四羧酸二酐或其衍生物之四羧酸成分之聚合反應獲得之聚醯亞胺前驅物及係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種, The present invention is a liquid crystal alignment agent characterized by containing the following components (A) and (B), a liquid crystal alignment film obtained from the liquid crystal alignment agent, and a liquid crystal display element having the liquid crystal alignment film. Component (A): Polymer (P), obtained from the polymerization reaction of a diamine component containing a diamine represented by the following formula (1) and a tetracarboxylic acid component containing an aromatic tetracarboxylic dianhydride or its derivatives At least one of the group consisting of polyimide precursors and polyimides that are imides of the polyimide precursors,
[化1] [chemical 1]
式中,R 1各自獨立地表示氫原子、或碳數1~3之1價有機基,R 1中之至少2個表示碳數1~3之1價有機基。R 1擁有之氫原子之一部分或全部亦可被取代。又,苯環上之氫原子之一部分或全部也可被取代基取代。L表示單鍵、或2價連結基。 (B)成分:具有2個以上之交聯性基之化合物。 In the formula, R 1 each independently represent a hydrogen atom or a monovalent organic group having 1 to 3 carbons, and at least two of R 1 represent a monovalent organic group having 1 to 3 carbons. Part or all of the hydrogen atoms possessed by R 1 may be substituted. In addition, some or all of the hydrogen atoms on the benzene ring may be substituted by substituents. L represents a single bond or a divalent linking group. (B) Component: A compound having two or more crosslinkable groups.
又,本說明書通篇中,鹵素原子可列舉氟原子、氯原子、溴原子、碘原子等,*表示原子鍵。 (發明之效果) In addition, throughout this specification, a halogen atom includes a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, etc., and * represents an atomic bond. (Effect of Invention)
依照本發明,可獲得即使添加了交聯性化合物仍可形成具有高光透射率及高電壓保持率之液晶配向膜之液晶配向劑、由該液晶配向劑獲得之液晶配向膜、及具有該液晶配向膜之液晶顯示元件。 本發明之可獲得上述效果之機轉並不一定明瞭,大致推測如下。藉由使用涉及聚合之胺基之鄰位被取代之特定芳香族二胺作為聚醯亞胺之原料單體,獲得之聚醯亞胺會具有來自π共軛被切斷之芳香族酸二酐之骨架。藉此,可抑制CT遷移,獲得聚醯亞胺膜之透明性提高之效果。 又,藉由使用上述特定芳香族二胺,分子間堆疊受阻礙,膜中出現空隙,電子在膜中之移動受抑制,結果聚醯亞胺膜的電阻增高。如此,以決定電壓保持率之因子之一之C(電容)及R(電阻)之積表示之CR時間常數可提高,獲得之液晶配向膜具有高電壓保持率。再者,本發明之液晶配向劑含有之交聯性化合物有多個交聯性基,故容易和聚合物(P)發生交聯反應。所以,聚合物(P)擁有之羧基等極性基減少,獲得之液晶配向膜有更高的電壓保持率。 According to the present invention, it is possible to obtain a liquid crystal alignment agent capable of forming a liquid crystal alignment film having high light transmittance and high voltage retention even when a crosslinking compound is added, a liquid crystal alignment film obtained from the liquid crystal alignment agent, and a liquid crystal alignment film having the liquid crystal alignment film. Film liquid crystal display element. The mechanism of the present invention to obtain the above-mentioned effects is not necessarily clear, but it is roughly estimated as follows. By using a specific aromatic diamine whose ortho-position of the amine group involved in polymerization is substituted as a raw material monomer of polyimide, the obtained polyimide will have aromatic acid dianhydride derived from π-conjugation cleavage The skeleton. Thereby, CT migration can be suppressed and the effect of improving the transparency of the polyimide film can be obtained. Also, by using the above-mentioned specific aromatic diamine, intermolecular stacking is hindered, voids appear in the film, electron movement in the film is suppressed, and as a result, the resistance of the polyimide film increases. In this way, the CR time constant represented by the product of C (capacitance) and R (resistance), which is one of the factors determining the voltage retention ratio, can be increased, and the obtained liquid crystal alignment film has a high voltage retention ratio. Furthermore, the cross-linking compound contained in the liquid crystal alignment agent of the present invention has multiple cross-linking groups, so it is easy to undergo a cross-linking reaction with the polymer (P). Therefore, the polar groups such as carboxyl groups possessed by the polymer (P) are reduced, and the obtained liquid crystal alignment film has a higher voltage holding ratio.
本發明之液晶配向劑,如上述,其特徵為含有聚合物(P),該聚合物(P)係選自由含有上式(1)表示之二胺(以下也稱為特定二胺)之二胺成分與含有芳香族四羧酸二酐或其衍生物之四羧酸成分之聚合反應獲得之聚醯亞胺前驅物及係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種。 式(1)中之R 1之碳數1~3之1價有機基可列舉碳數1~3之烷基(較佳為甲基、乙基、正丙基或異丙基。)、碳數1~3之烷氧基、碳數2~3之烷氧基烷基。考量提高電壓保持率之觀點,2~4個R 1為碳數1~3之1價有機基較佳。又,考量提高與交聯性化合物之反應性並提高電壓保持率之觀點,R 1之至少2個為甲基、或甲氧基更理想。 R 1擁有之氫原子之一部分或全部也可被取代,該取代基可列舉鹵素原子、羥基、氰基等。又,苯環上之氫原子之一部分或全部亦可被碳數1~3之1價有機基(具體例可列舉上述R 1之1價有機基之例)、鹵素原子、羥基、氰基等取代基取代。 The liquid crystal alignment agent of the present invention, as mentioned above, is characterized in that it contains a polymer (P), and the polymer (P) is selected from two diamines (hereinafter also referred to as specific diamines) represented by the above formula (1). Polyimide precursor obtained by polymerization reaction of amine component and tetracarboxylic acid component containing aromatic tetracarboxylic dianhydride or its derivatives and polyimide which is imide of the polyimide precursor At least one of the formed groups. The monovalent organic group of R 1 in formula (1) having 1 to 3 carbons can include an alkyl group with 1 to 3 carbons (preferably methyl, ethyl, n-propyl or isopropyl.), carbon Alkoxy with 1 to 3 carbons, alkoxyalkyl with 2 to 3 carbons. In view of improving the voltage retention rate, 2 to 4 R 1s are preferably monovalent organic groups with 1 to 3 carbon atoms. Also, from the viewpoint of improving the reactivity with the crosslinkable compound and increasing the voltage retention, it is more preferable that at least two of R 1 are methyl groups or methoxy groups. Part or all of the hydrogen atoms possessed by R 1 may be substituted, and examples of such substituents include halogen atoms, hydroxyl groups, and cyano groups. In addition, a part or all of the hydrogen atoms on the benzene ring can also be replaced by a monovalent organic group with 1 to 3 carbons (specific examples can include the example of the monovalent organic group of R1 above), a halogen atom, a hydroxyl group, a cyano group, etc. Substituents replace.
上式(1)中,L之2價連結基可列舉-O-、-S-、-SO-、-SO 2-、-CO-、-C(=O)-O-、-NR-(R表示氫原子或碳數1~6之烷基)、-CONR-(R表示氫原子或碳數1~6之烷基。)、-CH 2-、碳數2~12之直鏈狀或分支狀伸烷基、前述伸烷基擁有之任意-CH 2-被-O-、-CO-、-C(=O)-O-、-NR-(R表示氫原子或碳數1~6之烷基)、或-CONR-(R表示氫原子或碳數1~6之烷基)中之任一者取代之2價有機基、碳數5~6之伸環烷基、伸苯基、伸苯基二氧基、-Si(R 3)(R 4)-(R 3及R 4各自獨立地表示碳數1~6之烷基或烷氧基。)、及-(Q) s-(R 5) t-(-Si(R 3)(R 4)-O-) r-Si(R 3)(R 4)-(R 5) t’-(Q) s’-(R 3及R 4各自獨立地表示碳數1~6之烷基或烷氧基。R 5各自獨立地表示碳數1~6之伸烷基。Q表示-O-或-S-。r為0~20之整數。s、s’、t、t’為0或1之整數,s、s’、t、t’中之至少一者為1。多個R 3、R 4、R 5及Q可各自相同也可不同。 In the above formula (1), the divalent linking group of L includes -O-, -S-, -SO-, -SO 2 -, -CO-, -C(=O)-O-, -NR-( R represents a hydrogen atom or an alkyl group with a carbon number of 1 to 6), -CONR- (R represents a hydrogen atom or an alkyl group with a carbon number of 1 to 6.), -CH 2 -, a straight chain with a carbon number of 2 to 12 or Branched alkylene group, any -CH 2 -of the aforementioned alkylene group is replaced by -O-, -CO-, -C(=O)-O-, -NR- (R represents a hydrogen atom or a carbon number of 1 to 6 Alkyl), or -CONR- (R represents a hydrogen atom or an alkyl group with 1 to 6 carbons), a divalent organic group substituted by any of them, a cycloalkylene group with 5 to 6 carbons, and a phenylene group , phenylenedioxy, -Si(R 3 )(R 4 )-(R 3 and R 4 each independently represent an alkyl or alkoxy group with 1 to 6 carbon atoms.), and -(Q) s -(R 5 ) t -(-Si(R 3 )(R 4 )-O-) r -Si(R 3 )(R 4 )-(R 5 ) t' -(Q) s' -(R 3 and R 4 each independently represent an alkyl or alkoxy group with 1 to 6 carbons. R 5 each independently represent an alkylene group with 1 to 6 carbons. Q represents -O- or -S-. r is 0 to Integer of 20. s, s', t, t' are integers of 0 or 1, at least one of s, s', t, t' is 1. A plurality of R 3 , R 4 , R 5 and Q can be They may be the same or different.
該等之中,考量理想地獲得本發明之效果之觀點,上式(1)之L之2價連結基為-CH 2-、碳數2~12之直鏈狀或分支狀伸烷基更理想。 上述2價連結基擁有之氫原子之一部分或全部也可被取代,該取代基可列舉鹵素原子、羥基、氰基等。 Among these, in view of ideally obtaining the effects of the present invention, the divalent linking group of L in the above formula (1) is -CH 2 -, a linear or branched alkylene group having 2 to 12 carbon atoms. ideal. Part or all of the hydrogen atoms possessed by the above-mentioned divalent linking group may be substituted, and examples of such substituents include halogen atoms, hydroxyl groups, and cyano groups.
上式(1)表示之二胺之理想具體例可列舉下式(d1-1)~(d1-6)表示之二胺,其中,考量理想地獲得本發明之效果之觀點,(d1-1)~(d1-3)表示之二胺更理想。Desirable specific examples of the diamine represented by the above formula (1) include diamines represented by the following formulas (d1-1) to (d1-6), wherein, considering the viewpoint of obtaining the effect of the present invention ideally, (d1-1 )~(d1-3) The diamines represented are more ideal.
[化2] [Chem 2]
式中,A、B、C、D各自獨立地表示氫原子、甲基、乙基、異丙基、甲氧基、或甲氧基甲基,A~D中之至少2個為氫原子以外之基。更佳為A、B各自獨立地表示甲基、乙基、異丙基、甲氧基、或甲氧基甲基,C、D各自獨立地表示氫原子、或上述A、B定義之基。A、B、C、D又更佳為各自獨立地表示甲基、乙基、異丙基、甲氧基、或甲氧基甲基,A~D中之至少2個表示甲基或乙基。E表示單鍵、-CH 2-、-(CH 2) 2-、-O-、-S-、-CO-、-SO-、-SO 2-、-C(=O)-O-、-CONH-、-CO-N(CH 3)-、-NH-、-N(CH 3)-、-Si(CH 3) 2-、-Si(OCH 3) 2-、-O-Si(CH 3) 2-O-、伸苯基、-C(CH 3) 2-、或-C(CF 3) 2-。 上式(d1-1)~(d1-3)中,A、B、C、D、E之理想組合(A、B、C、D、E)可列舉以下之態樣; (甲基,甲基,氫原子,氫原子,-CH 2-)、(甲基,乙基,氫原子,氫原子,-CH 2-)、(乙基,乙基,氫原子,氫原子,-CH 2-)、(異丙基,異丙基,氫原子,氫原子,-CH 2-)、(甲氧基甲基,甲氧基甲基,氫原子,氫原子,-CH 2-)、(甲基,甲基,甲基,氫原子,-CH 2-)、(乙基,乙基,乙基,氫原子,-CH 2-)、(異丙基,異丙基,甲基,甲基,-CH 2-)、(甲氧基甲基,甲氧基甲基,甲基,氫原子,-CH 2-)、(甲基,乙基,甲基,氫原子,-CH 2-)、(甲氧基甲基,甲氧基甲基,甲氧基甲基,甲氧基甲基,-CH 2-)、(甲基,甲基,甲基,甲基,-CH 2-)、(乙基,甲基,甲基,乙基,-CH 2-)、(乙基,乙基,乙基,乙基,-CH 2-)、(甲基,甲基,乙基,乙基,-CH 2-)、(乙基,乙基,異丙基,異丙基,-CH 2-)、(異丙基,異丙基,異丙基,異丙基,-CH 2-)、(異丙基,異丙基,甲基,氫原子,-CH 2-)、(甲氧基,甲氧基,甲基,甲基,-CH 2-);(甲基,甲基,氫原子,氫原子,-O-)、(乙基,乙基,氫原子,氫原子,-O-)、(甲基,甲基,甲基,氫原子,-O-)、(甲基,甲基,甲基,甲基,-O-)、(甲基,甲基,乙基,乙基,-O-);(甲基,甲基,氫原子,氫原子,-S-)、(乙基,乙基,氫原子,氫原子,-S-)、(甲基,甲基,甲基,氫原子,-S-)、(甲基,甲基,甲基,甲基,-S-)、(乙基,乙基,乙基,乙基,-S-)、(甲基,甲基,乙基,乙基,-S-);(甲基,甲基,甲基,氫原子,-CO-)、(甲基,甲基,氫原子,氫原子,-CO-)、(甲基,甲基,甲基,甲基,-CO-);(甲基,甲基,乙基,氫原子,-SO 2-)、(甲基,甲基,氫原子,氫原子,-SO 2-)、(甲基,甲基,甲基,甲基,-SO 2-)、(乙基,乙基,甲基,甲基,-SO 2-);(甲基,甲基,甲基,甲基,-SO-)、(甲基,甲基,氫原子,氫原子,-SO-);(甲基,甲基,氫原子,氫原子,-C(=O)-O-)、(甲基,甲基,甲基,甲基,-C(=O)-O-); (甲基,甲基,氫原子,氫原子,-CO-N(CH 3)-);(甲基,甲基,乙基,乙基,-N(CH 3)-)、(甲基,甲基,甲基,甲基,-N(CH 3)-);(甲基,甲基,氫原子,氫原子,-CO-NH-);(乙基,甲基,乙基,甲基,-NH-)、(甲基,甲基,甲基,甲基,-NH-);(甲基,甲基,氫原子,氫原子,-Si(CH 3) 2-);(乙基,乙基,氫原子,氫原子,-Si(OCH 3) 2-);(甲基,甲基,甲基,甲基,-O-Si(CH 3) 2-O-);(甲基,甲基,氫原子,氫原子,-(CH 2) 2-)、(甲基,甲基,甲基,甲基,-(CH 2) 2-)、(乙基,乙基,氫原子,氫原子,-(CH 2) 2-)、(甲基,甲基,乙基,乙基,-(CH 2) 2-);(甲基,甲基,甲基,甲基,伸苯基)、(乙基,乙基,氫原子,氫原子,伸苯基);(甲基,乙基,甲基,乙基,-C(CH 3) 2-)、(甲基,甲基,甲基,甲基,-C(CH 3) 2-);(甲基,甲基,甲基,甲基,-C(CF 3) 2-); (甲基,甲基,氫原子,氫原子,單鍵)、(甲基,氫原子,甲基,氫原子,單鍵)、(三氟甲基,氫原子,三氟甲基,氫原子,單鍵)、(甲氧基,氫原子,甲氧基,氫原子,單鍵)、(甲基,乙基,甲基,乙基,單鍵)、(甲基,乙基,甲基,氫原子,單鍵)、(乙基,乙基,乙基,乙基,單鍵)、(甲氧基,甲氧基,甲氧基,甲氧基,單鍵)、(異丙基,異丙基,氫原子,氫原子,單鍵)、(甲氧基甲基,甲氧基甲基,甲氧基甲基,甲氧基甲基,單鍵)。 In the formula, A, B, C, and D each independently represent a hydrogen atom, methyl, ethyl, isopropyl, methoxy, or methoxymethyl, and at least two of A to D are hydrogen atoms foundation. More preferably, A and B each independently represent methyl, ethyl, isopropyl, methoxy, or methoxymethyl, and C and D each independently represent a hydrogen atom or a group as defined above for A and B. A, B, C, and D are more preferably each independently representing a methyl group, an ethyl group, an isopropyl group, a methoxy group, or a methoxymethyl group, and at least two of A to D represent a methyl group or an ethyl group . E represents a single bond, -CH 2 -, -(CH 2 ) 2 -, -O-, -S-, -CO-, -SO-, -SO 2 -, -C(=O)-O-, - CONH-, -CO-N(CH 3 )-, -NH-, -N(CH 3 )-, -Si(CH 3 ) 2 -, -Si(OCH 3 ) 2 -, -O-Si(CH 3 ) 2 -O-, phenylene, -C(CH 3 ) 2 -, or -C(CF 3 ) 2 -. In the above formulas (d1-1) ~ (d1-3), the ideal combination of A, B, C, D, E (A, B, C, D, E) can enumerate the following aspects; (methyl, methyl group, hydrogen atom, hydrogen atom, -CH 2 -), (methyl, ethyl, hydrogen atom, hydrogen atom, -CH 2 -), (ethyl, ethyl, hydrogen atom, hydrogen atom, -CH 2 - ), (isopropyl, isopropyl, hydrogen atom, hydrogen atom, -CH 2 -), (methoxymethyl, methoxymethyl, hydrogen atom, hydrogen atom, -CH 2 -), (form base, methyl, methyl, hydrogen atom, -CH 2 -), (ethyl, ethyl, ethyl, hydrogen atom, -CH 2 -), (isopropyl, isopropyl, methyl, methyl , -CH 2 -), (methoxymethyl, methoxymethyl, methyl, hydrogen atom, -CH 2 -), (methyl, ethyl, methyl, hydrogen atom, -CH 2 -) , (methoxymethyl, methoxymethyl, methoxymethyl, methoxymethyl, -CH 2 -), (methyl, methyl, methyl, methyl, -CH 2 -) , (ethyl, methyl, methyl, ethyl, -CH 2 -), (ethyl, ethyl, ethyl, ethyl, -CH 2 -), (methyl, methyl, ethyl, ethyl base, -CH 2 -), (ethyl, ethyl, isopropyl, isopropyl, -CH 2 -), (isopropyl, isopropyl, isopropyl, isopropyl, -CH 2 - ), (isopropyl, isopropyl, methyl, hydrogen atom, -CH 2 -), (methoxy, methoxy, methyl, methyl, -CH 2 -); (methyl, methyl , hydrogen atom, hydrogen atom, -O-), (ethyl, ethyl, hydrogen atom, hydrogen atom, -O-), (methyl, methyl, methyl, hydrogen atom, -O-), (form base, methyl, methyl, methyl, -O-), (methyl, methyl, ethyl, ethyl, -O-); (methyl, methyl, hydrogen atom, hydrogen atom, -S- ), (ethyl, ethyl, hydrogen atom, hydrogen atom, -S-), (methyl, methyl, methyl, hydrogen atom, -S-), (methyl, methyl, methyl, methyl , -S-), (ethyl, ethyl, ethyl, ethyl, -S-), (methyl, methyl, ethyl, ethyl, -S-); (methyl, methyl, methyl Base, hydrogen atom, -CO-), (methyl, methyl, hydrogen atom, hydrogen atom, -CO-), (methyl, methyl, methyl, methyl, -CO-); (methyl, Methyl, ethyl, hydrogen atom, -SO 2 -), (methyl, methyl, hydrogen atom, hydrogen atom, -SO 2 -), (methyl, methyl, methyl, methyl, -SO 2 -), (ethyl, ethyl, methyl, methyl, -SO 2 -); (methyl, methyl, methyl, methyl, -SO-), (methyl, methyl, hydrogen atom, hydrogen atom, -SO-); (methyl, methyl, hydrogen atom, hydrogen atom, -C(=O)-O-), (methyl, methyl, methyl, methyl, -C(=O )-O-); (methyl, methyl, hydrogen atom, hydrogen atom, -CO-N(CH 3 )-); (methyl, methyl, ethyl, ethyl, -N(CH 3 )- ), (methyl, methyl, methyl, methyl, -N(CH 3 )-); (methyl, methyl, hydrogen atom, hydrogen atom, -CO-NH-); (ethyl, methyl , ethyl, methyl, -NH-), (methyl, methyl, methyl, methyl, -NH-); (methyl, methyl, hydrogen atom, hydrogen atom, -Si(CH 3 ) 2 -); (ethyl, ethyl, hydrogen atom, hydrogen atom, -Si(OCH 3 ) 2 -); (methyl, methyl, methyl, methyl, -O-Si(CH 3 ) 2 -O -); (methyl, methyl, hydrogen atom, hydrogen atom, -(CH 2 ) 2 -), (methyl, methyl, methyl, methyl, -(CH 2 ) 2 -), (ethyl , ethyl, hydrogen atom, hydrogen atom, -(CH 2 ) 2 -), (methyl, methyl, ethyl, ethyl, -(CH 2 ) 2 -); (methyl, methyl, methyl , methyl, phenylene), (ethyl, ethyl, hydrogen atom, hydrogen atom, phenylene); (methyl, ethyl, methyl, ethyl, -C(CH 3 ) 2 -), (methyl, methyl, methyl, methyl, -C(CH 3 ) 2 -); (methyl, methyl, methyl, methyl, -C(CF 3 ) 2 -); (methyl, methyl group, hydrogen atom, hydrogen atom, single bond), (methyl group, hydrogen atom, methyl group, hydrogen atom, single bond), (trifluoromethyl group, hydrogen atom, trifluoromethyl group, hydrogen atom, single bond) , (methoxy, hydrogen atom, methoxy, hydrogen atom, single bond), (methyl, ethyl, methyl, ethyl, single bond), (methyl, ethyl, methyl, hydrogen atom, single bond), (ethyl, ethyl, ethyl, ethyl, single bond), (methoxy, methoxy, methoxy, methoxy, single bond), (isopropyl, isopropyl , hydrogen atom, hydrogen atom, single bond), (methoxymethyl, methoxymethyl, methoxymethyl, methoxymethyl, single bond).
(聚合物(P)之製造) 本發明之液晶配向劑含有之聚合物(P),係使用含有特定二胺之二胺成分獲得之聚醯亞胺前驅物、或係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺。其中,聚醯亞胺前驅物係可藉由將聚醯胺酸、聚醯胺酸酯等予以醯亞胺化而獲得聚醯亞胺之聚合物。 (Manufacture of Polymer (P)) The polymer (P) contained in the liquid crystal alignment agent of the present invention is a polyimide precursor obtained by using a diamine component containing a specific diamine, or a polyamide that is an imide of the polyimide precursor imine. Among them, the polyimide precursor is a polyimide polymer obtained by imidizing polyamic acid, polyamic acid ester, and the like.
上述聚合物(P)之聚醯亞胺前驅物即聚醯胺酸(P’),可藉由上述含有特定二胺之二胺成分與四羧酸成分之聚合反應獲得。特定二胺可單獨使用一種也可將二種以上組合使用。The polyimide precursor of the above-mentioned polymer (P), that is, polyamic acid (P'), can be obtained by the polymerization reaction of the above-mentioned diamine component containing a specific diamine and a tetracarboxylic acid component. Specific diamines may be used alone or in combination of two or more.
於此情形,特定二胺之使用量相對於全部二胺成分為5莫耳%以上較理想,10莫耳%以上更佳,20莫耳%以上又更佳。In this case, the usage-amount of a specific diamine is desirably 5 mol% or more with respect to the whole diamine component, More preferably, it is 10 mol% or more, More preferably, it is 20 mol% or more.
上述聚醯胺酸(P’)之製造使用的二胺成分,也可含有特定二胺以外之二胺(以下也稱為其他二胺)。上述特定二胺以外更併用其他二胺時,特定二胺相對於二胺成分之使用量為90莫耳%以下較理想,80莫耳%以下更理想。以下列舉其他二胺之例,但本發明不限於此等。上述其他二胺可單獨使用一種也可將二種以上組合使用。 「A-X-J」(針對A、X、及J之定義,如後述。)表示之芳香族二胺(d)、對苯二胺、2,3,5,6-四甲基-對苯二胺、2,5-二甲基-對苯二胺、間苯二胺、2,4-二甲基-間苯二胺、2,5-二胺基甲苯、2,6-二胺基甲苯、2,2’-二甲基-4,4’-二胺基聯苯、3,3’-二羥基-4,4’-二胺基聯苯、2,2’-二氟-4,4’-二胺基聯苯、3,3’-二氟-4,4’-二胺基聯苯、2,2’-雙(三氟甲基)-4,4’-二胺基聯苯、3,4’-二胺基聯苯、4,4’-二胺基聯苯、3,3’-二胺基聯苯、2,2’-二胺基聯苯、2,3’-二胺基聯苯、1,5-二胺基萘、1,6-二胺基萘、1,7-二胺基萘、2,5-二胺基萘、2,6-二胺基萘、2,7-二胺基萘、雙(4-胺基苯氧基)甲烷、1,2-雙(4-胺基苯基)乙烷、1,2-雙(4-胺基苯氧基)乙烷、1,3-雙(3-胺基苯基)丙烷、1,4-雙(4-胺基苯基)丁烷、1,4-雙(4-胺基-2-甲基苯氧基)丁烷、1,4-雙(3-胺基苯基)丁烷、1,5-雙(4-胺基苯氧基)戊烷、1,5-雙(3-胺基苯氧基)戊烷、1,6-雙(4-胺基苯氧基)己烷、1,6-雙(3-胺基苯氧基)己烷、1,7-雙(4-胺基苯氧基)庚烷、1,7-雙(3-胺基苯氧基)庚烷、1,8-雙(4-胺基苯氧基)辛烷、1,8-雙(3-胺基苯氧基)辛烷、1,9-雙(4-胺基苯氧基)壬烷、1,9-雙(3-胺基苯氧基)壬烷、1,10-雙(4-胺基苯氧基)癸烷、1,10-雙(3-胺基苯氧基)癸烷、1,11-雙(4-胺基苯氧基)十一烷、1,11-雙(3-胺基苯氧基)十一烷、1,12-雙(4-胺基苯氧基)十二烷、1,12-雙(3-胺基苯氧基)十二烷、3-[2-[2-(4-胺基苯氧基)乙氧基]乙氧基]苯胺、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯基)苯、1,3-雙(4-胺基苯基)苯、4,4’-雙(4-胺基苯氧基)聯苯、4,4’-雙(4-胺基苯氧基)二苯醚、1,4-雙[4-(4-胺基苯氧基)苯氧基]苯、1,2-雙(6-胺基-2-萘氧基)乙烷、1,2-雙(6-胺基-2-萘基)乙烷、6-[2-(4-胺基苯氧基)乙氧基]-2-萘胺、4’-[2-(4-胺基苯氧基)乙氧基]-[1,1’-聯苯]-4-胺、1,4-雙[2-(4-胺基苯基)乙基]丁二酸酯、1,6-雙[2-(4-胺基苯基)乙基]己二酸酯、1,4-伸苯基雙(4-胺基苯甲酸酯)、1,4-伸苯基雙(3-胺基苯甲酸酯)、1,3-伸苯基雙(4-胺基苯甲酸酯)、1,3-伸苯基雙(3-胺基苯甲酸酯)、雙(4-胺基苯基)對苯二甲酸酯、雙(3-胺基苯基)對苯二甲酸酯、雙(4-胺基苯基)間苯二甲酸酯、雙(3-胺基苯基)間苯二甲酸酯、;4,4’-二胺基偶氮苯、二胺基二苯基乙炔(diaminotolan)、4,4-二胺基查耳酮等具有光配向性基之二胺;甲基丙烯酸2-(2,4-二胺基苯氧基)乙酯及2,4-二胺基-N,N-二烯丙基苯胺等末端具有光聚合性基之二胺;1-(4-(2-(2,4-二胺基苯氧基)乙氧基)苯基)-2-羥基-2-甲基丙酮、2-(4-(2-羥基-2-甲基丙醯基)苯氧基)乙基-3,5-二胺基苯甲酸酯為代表之苯偶因或其烷醚化物、苄基縮酮類、苯乙酮類、醯基氧化膦類、二苯基酮類、或胺基二苯基酮類等分子內具有展現自由基聚合起始劑作用之基之二胺(以下也稱為有自由基開始作用之二胺);4,4’-二胺基苯醯替苯胺等具有醯胺鍵之二胺、1,3-雙(4-胺基苯基)脲、1,3-雙(4-胺基苄基)脲、1,3-雙(4-胺基苯乙基)脲等具有脲鍵之二胺;4,4’-磺醯基二苯胺、3,3’-磺醯基二苯胺、雙(4-胺基苯基)矽烷、雙(3-胺基苯基)矽烷、二甲基-雙(4-胺基苯基)矽烷、二甲基-雙(3-胺基苯基)矽烷、4,4’-硫二苯胺、3,3’-硫二苯胺、3,3’-二胺基二苯醚、3,4’-二胺基二苯醚、4,4’-二胺基二苯醚、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2-雙(3-胺基苯基)六氟丙烷、2,2-雙(3-胺基-4-甲基苯基)六氟丙烷、2,2-雙(4-胺基苯基)丙烷、2,2-雙(3-胺基苯基)丙烷、2,2-雙(3-胺基-4-甲基苯基)丙烷、3,3’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基酮、1,4-雙(4-胺基苯基)苯、1,3-雙(4-胺基苯基)苯、1,4-雙(4-胺基苄基)苯;2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嘧啶、3,6-二胺基咔唑、N-甲基-3,6-二胺基咔唑、1,4-雙-(4-胺基苯基)-哌𠯤、3,6-二胺基吖啶、N-乙基-3,6-二胺基咔唑、N-苯基-3,6-二胺基咔唑、N-(3-(1H-咪唑-1-基)丙基-3,5-二胺基苯甲醯胺、4-[4-[(4-胺基苯氧基)甲基]-4,5-二氫-4-甲基-2-㗁唑基]-苯胺、1,4-雙(p-胺基苄基)哌𠯤、4,4’-[丙烷-1,3-二基雙(哌啶-1,4-二基)]二苯胺、4-(4-胺基苯氧基羰基)-1-(4-胺基苯基)哌啶、下式(z-1)~式(z-5)表示之二胺(式(z-2)中之m,各自獨立地具有下列定義)、2,5-雙(4-胺基苯基)吡咯、4,4’-(1-甲基-1H-吡咯-2,5-二基)雙[苯胺]、1,4-雙-(4-胺基苯基)-哌𠯤、2-N-(4-胺基苯基)吡啶-2,5-二胺、2-N-(5-胺基吡啶-2-基)吡啶-2,5-二胺、2-(4-胺基苯基)-5-胺基苯并咪唑、2-(4-胺基苯基)-6-胺基苯并咪唑、5-(1H-苯并咪唑-2-基)苯-1,3-二胺等含雜環之二胺、或4,4’-二胺基二苯胺、4,4’-二胺基二苯基-N-甲胺、N,N’-雙(4-胺基苯基)-1,4-苯二胺、N,N ’-雙(4-胺基苯基)-聯苯胺、N,N’-雙(4-胺基苯基)-N,N’-二甲基聯苯胺、或N,N’-雙(4-胺基苯基)-N,N’-二甲基-1,4-苯二胺等具有二苯胺結構之二胺為代表之具有選自由含氮雜環、二級胺基及三級胺基構成之群組中之至少一種含氮結構(以下亦稱為特定之含氮結構。)之二胺(惟分子內不具有鍵結了因加熱而脫離且取代為氫原子之保護基之胺基。);2,4-二胺基苯甲酸、2,5-二胺基苯甲酸、3,5-二胺基苯甲酸、4,4’-二胺基聯苯-3-羧酸、4,4’-二胺基二苯基甲烷-3-羧酸、1,2-雙(4-胺基苯基)乙烷-3-羧酸、4,4’-二胺基聯苯-3,3’-二羧酸、4,4’-二胺基聯苯-2,2’-二羧酸、3,3’-二胺基聯苯-4,4’-二羧酸、3,3’-二胺基聯苯-2,4’-二羧酸、4,4’-二胺基二苯基甲烷-3,3’-二羧酸、1,2-雙(4-胺基苯基)乙烷-3,3’-二羧酸、及4,4’-二胺基二苯醚-3,3’-二羧酸等具有羧基之二胺;2,4-二胺基苯酚、3,5-二胺基苯酚、3,5-二胺基苯甲醇、2,4-二胺基苯甲醇、4,6-二胺基間苯二酚、4,4’-二胺基-3,3’-二羥基聯苯;4-(2-(甲胺基)乙基)苯胺、4-(2-胺基乙基)苯胺、1-(4-胺基苯基)-1,3,3-三甲基-1H-二氫茚-5-胺、1-(4-胺基苯基)-2,3-二氫-1,3,3-三甲基-1H-茚-6-胺;N,N’-雙(2-第三丁氧基羰胺基-4-胺基苯基)己二醯胺、4-胺基-N-(2-第三丁氧基羰胺基-4-胺基苯基)苯甲醯胺、胺甲酸N-[(2,5-二胺基苯基)甲基]-1,1-二甲基乙酯、胺甲酸,N-[3-(2,5-二胺基苯基)丙基]-1,1-二甲基乙酯、胺甲酸N,N-[(2,5-二胺基-1,3-伸苯基)二-3,1-丙烷二基]雙-C,C-雙(1,1-二甲基乙基)酯、N-第三丁氧基羰基-N-(2-(4-胺基苯基)乙基)-N-(4-胺基苄基)胺、苯甲酸4-胺基-2-第三丁氧基羰胺基-1,1’-[(1,1,3,3-四甲基-1,3-二矽氧烷二基)二-4,1-丁二基]酯、胺甲酸,N-[2-(4-胺基苯基)乙基]-N-[[[2-(4-胺基苯基)乙基]胺基]羰基]-1,1-二甲基乙酯、胺甲酸,N-(4-胺基苯基)-N-[[1-(4-胺基苯基)-4-哌啶基]甲基]-1,1-二甲基乙酯等具有基「-N(D)-」(D表示因加熱而脫離並取代為氫原子之保護基,較佳為第三丁氧基羰基。)之二胺;1-十二烷氧基-2,4-二胺基苯、1-十四烷氧基-2,4-二胺基苯、1-十五烷氧基-2,4-二胺基苯、1-十六烷氧基-2,4-二胺基苯、1-十八烷氧基-2,4-二胺基苯、1-十二烷氧基-2,5-二胺基苯、1-十四烷氧基-2,5-二胺基苯、1-十五烷氧基-2,5-二胺基苯、1-十六烷氧基-2,5-二胺基苯、1-十八烷氧基-2,5-二胺基苯為代表之具有碳數12~20之長鏈烷基之芳香族二胺;1,3-雙(3-胺基丙基)-四甲基二矽氧烷、1,3-雙[3-(對胺基苯基胺甲醯基)丙基]四甲基二矽氧烷等具有矽氧烷鍵之二胺;間亞二甲苯二胺、1,3-丙烷二胺、四亞甲基二胺、五亞甲基二胺、六亞甲基二胺、1,3-雙(胺基甲基)環己烷、1,4-二胺基環己烷、4,4’-亞甲基雙(環己胺)、國際公開第2018/117239號記載之式(Y-1)~(Y-167)中之任一者表示之基鍵結了2個胺基之二胺等。 The diamine component used in the production of the polyamic acid (P') may contain diamines other than the specific diamine (hereinafter also referred to as other diamines). When other diamines are used in combination with the above-mentioned specific diamine, the usage-amount of a specific diamine with respect to a diamine component is desirably 90 mol % or less, More preferably, it is 80 mol % or less. Examples of other diamines are listed below, but the present invention is not limited thereto. The above-mentioned other diamines may be used alone or in combination of two or more. Aromatic diamine (d), p-phenylenediamine, 2,3,5,6-tetramethyl-p-phenylenediamine, 2,5-Dimethyl-p-phenylenediamine, m-phenylenediamine, 2,4-dimethyl-m-phenylenediamine, 2,5-diaminotoluene, 2,6-diaminotoluene, 2 ,2'-Dimethyl-4,4'-diaminobiphenyl, 3,3'-dihydroxy-4,4'-diaminobiphenyl, 2,2'-difluoro-4,4' -diaminobiphenyl, 3,3'-difluoro-4,4'-diaminobiphenyl, 2,2'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 3,4'-diaminobiphenyl, 4,4'-diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2'-diaminobiphenyl, 2,3'-bis Aminobiphenyl, 1,5-diaminonaphthalene, 1,6-diaminonaphthalene, 1,7-diaminonaphthalene, 2,5-diaminonaphthalene, 2,6-diaminonaphthalene, 2,7-diaminonaphthalene, bis(4-aminophenoxy)methane, 1,2-bis(4-aminophenyl)ethane, 1,2-bis(4-aminophenoxy) ) ethane, 1,3-bis(3-aminophenyl)propane, 1,4-bis(4-aminophenyl)butane, 1,4-bis(4-aminophenyl)-2-methyl Phenoxy)butane, 1,4-bis(3-aminophenyl)butane, 1,5-bis(4-aminophenoxy)pentane, 1,5-bis(3-amino Phenoxy)pentane, 1,6-bis(4-aminophenoxy)hexane, 1,6-bis(3-aminophenoxy)hexane, 1,7-bis(4-amine phenoxy)heptane, 1,7-bis(3-aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane, 1,8-bis(3- Aminophenoxy)octane, 1,9-bis(4-aminophenoxy)nonane, 1,9-bis(3-aminophenoxy)nonane, 1,10-bis(4 -aminophenoxy)decane, 1,10-bis(3-aminophenoxy)decane, 1,11-bis(4-aminophenoxy)undecane, 1,11-bis (3-aminophenoxy)undecane, 1,12-bis(4-aminophenoxy)dodecane, 1,12-bis(3-aminophenoxy)dodecane, 3 -[2-[2-(4-Aminophenoxy)ethoxy]ethoxy]aniline, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4- Aminophenoxy)benzene, 1,4-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 4,4'-bis(4-aminophenyl)benzene oxy)biphenyl, 4,4'-bis(4-aminophenoxy)diphenyl ether, 1,4-bis[4-(4-aminophenoxy)phenoxy]benzene, 1, 2-bis(6-amino-2-naphthyloxy)ethane, 1,2-bis(6-amino-2-naphthyl)ethane, 6-[2-(4-aminophenoxy )ethoxy]-2-naphthylamine, 4'-[2-(4-aminophenoxy)ethoxy]-[1,1'-biphenyl]-4-amine, 1,4-bis [2-(4-aminophenyl)ethyl]succinate, 1,6-bis[2-(4-aminophenyl)ethyl]adipate, 1,4-phenylene Bis(4-aminobenzoate), 1,4-phenylene bis(3-aminobenzoate), 1,3-phenylene bis(4-aminobenzoate), 1,3-Phenylbis(3-aminobenzoate), bis(4-aminophenyl)terephthalate, bis(3-aminophenyl)terephthalate , bis(4-aminophenyl) isophthalate, bis(3-aminophenyl) isophthalate, ; 4,4'-diaminoazobenzene, diaminodi Phenylacetylene (diaminotolan), 4,4-diaminochalcone and other diamines with photoalignment groups; 2-(2,4-diaminophenoxy)ethyl methacrylate and 2,4 -Diamine-N,N-diallylaniline and other diamines with photopolymerizable groups at the end; 1-(4-(2-(2,4-diaminophenoxy)ethoxy)benzene base)-2-hydroxy-2-methylacetone, 2-(4-(2-hydroxy-2-methylpropionyl)phenoxy)ethyl-3,5-diaminobenzoate is Representative benzoin or its alkyl ethers, benzyl ketals, acetophenones, acyl phosphine oxides, diphenyl ketones, or amino diphenyl ketones exhibit free radical polymerization Diamines that act as bases for initiators (hereinafter also referred to as diamines with free radicals); 4,4'-diaminobenzoylaniline and other diamines with amide bonds, (4-aminophenyl)urea, 1,3-bis(4-aminobenzyl)urea, 1,3-bis(4-aminophenethyl)urea and other diamines with urea bonds; 4, 4'-sulfonyl diphenylamine, 3,3'-sulfonyl diphenylamine, bis(4-aminophenyl)silane, bis(3-aminophenyl)silane, dimethyl-bis(4- Aminophenyl)silane, Dimethyl-bis(3-aminophenyl)silane, 4,4'-thiodiphenylamine, 3,3'-thiodiphenylamine, 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 4,4'-diaminodiphenyl ether, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2, 2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis(3-aminophenyl base) hexafluoropropane, 2,2-bis(3-amino-4-methylphenyl)hexafluoropropane, 2,2-bis(4-aminophenyl)propane, 2,2-bis(3 -aminophenyl)propane, 2,2-bis(3-amino-4-methylphenyl)propane, 3,3'-diaminodiphenylmethane, 3,4'-diaminobis Phenylmethane, 4,4'-diaminodiphenylmethane, 4,4'-diaminobenzophenone, 1,4-bis(4-aminophenyl)benzene, 1,3-bis (4-aminophenyl)benzene, 1,4-bis(4-aminobenzyl)benzene; 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyridine Pyrimidine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, 1,4-bis-(4-aminophenyl)-piperone, 3,6-di Aminoacridine, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, N-(3-(1H-imidazol-1-yl)propane Base-3,5-diaminobenzamide, 4-[4-[(4-aminophenoxy)methyl]-4,5-dihydro-4-methyl-2-oxazolyl ]-aniline, 1,4-bis(p-aminobenzyl)piperone, 4,4'-[propane-1,3-diylbis(piperidine-1,4-diyl)]diphenylamine, 4-(4-aminophenoxycarbonyl)-1-(4-aminophenyl)piperidine, diamines represented by the following formula (z-1) ~ formula (z-5) (formula (z-2 ), each independently has the following definitions), 2,5-bis(4-aminophenyl)pyrrole, 4,4'-(1-methyl-1H-pyrrole-2,5-diyl) Bis[aniline], 1,4-bis-(4-aminophenyl)-piperone, 2-N-(4-aminophenyl)pyridine-2,5-diamine, 2-N-(5 -aminopyridin-2-yl)pyridine-2,5-diamine, 2-(4-aminophenyl)-5-aminobenzimidazole, 2-(4-aminophenyl)-6- Aminobenzimidazole, 5-(1H-benzimidazol-2-yl)benzene-1,3-diamine and other diamines containing heterocycles, or 4,4'-diaminodiphenylamine, 4,4 '-Diaminodiphenyl-N-methylamine, N,N'-bis(4-aminophenyl)-1,4-phenylenediamine, N,N'-bis(4-aminophenyl) )-benzidine, N,N'-bis(4-aminophenyl)-N,N'-dimethylbenzidine, or N,N'-bis(4-aminophenyl)-N,N Diamines having a diphenylamine structure such as '-dimethyl-1,4-phenylenediamine have at least one compound selected from the group consisting of nitrogen-containing heterocycles, secondary amine groups, and tertiary amine groups. Nitrogen structure (hereinafter also referred to as specific nitrogen-containing structure. ) of diamine (except that there is no amino group in the molecule bonded with a protecting group that is detached by heating and replaced by a hydrogen atom); 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid , 3,5-diaminobenzoic acid, 4,4'-diaminobiphenyl-3-carboxylic acid, 4,4'-diaminodiphenylmethane-3-carboxylic acid, 1,2-bis (4-Aminophenyl)ethane-3-carboxylic acid, 4,4'-diaminobiphenyl-3,3'-dicarboxylic acid, 4,4'-diaminobiphenyl-2,2 '-dicarboxylic acid, 3,3'-diaminobiphenyl-4,4'-dicarboxylic acid, 3,3'-diaminobiphenyl-2,4'-dicarboxylic acid, 4,4' -Diaminodiphenylmethane-3,3'-dicarboxylic acid, 1,2-bis(4-aminophenyl)ethane-3,3'-dicarboxylic acid, and 4,4'-bis Aminodiphenyl ether-3,3'-dicarboxylic acid and other diamines with carboxyl groups; 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2 ,4-diaminobenzyl alcohol, 4,6-diaminoresorcinol, 4,4'-diamino-3,3'-dihydroxybiphenyl; 4-(2-(methylamino) Ethyl)aniline, 4-(2-aminoethyl)aniline, 1-(4-aminophenyl)-1,3,3-trimethyl-1H-dihydroinden-5-amine, 1- (4-Aminophenyl)-2,3-dihydro-1,3,3-trimethyl-1H-inden-6-amine; N,N'-bis(2-tert-butoxycarbonylamine Base-4-aminophenyl)adipamide, 4-amino-N-(2-tert-butoxycarbonylamino-4-aminophenyl)benzamide, carbamic acid N-[ (2,5-diaminophenyl)methyl]-1,1-dimethylethyl ester, carbamic acid, N-[3-(2,5-diaminophenyl)propyl]-1, 1-Dimethyl ethyl ester, carbamic acid N,N-[(2,5-diamino-1,3-phenylene)di-3,1-propanediyl]bis-C,C-bis( 1,1-Dimethylethyl) ester, N-tert-butoxycarbonyl-N-(2-(4-aminophenyl)ethyl)-N-(4-aminobenzyl)amine, Benzoic acid 4-amino-2-tert-butoxycarbonylamino-1,1'-[(1,1,3,3-tetramethyl-1,3-disiloxanediyl)di- 4,1-Butanediyl]ester, carbamic acid, N-[2-(4-aminophenyl)ethyl]-N-[[[2-(4-aminophenyl)ethyl]amino ]carbonyl]-1,1-dimethylethyl ester, carbamic acid, N-(4-aminophenyl)-N-[[1-(4-aminophenyl)-4-piperidinyl]methanol Group]-1,1-dimethylethyl ester, etc. have the group "-N(D)-" (D represents a protecting group that is detached by heating and replaced by a hydrogen atom, preferably tertiary butoxycarbonyl.) Diamines; 1-dodecyloxy-2,4-diaminobenzene, 1-tetradecyloxy-2,4-diaminobenzene, 1-pentadecyloxy-2,4- Diaminobenzene, 1-hexadecyloxy-2,4-diaminobenzene, 1-octadecyloxy-2,4-diaminobenzene, 1-dodecyloxy-2,5 -Diaminobenzene, 1-tetradecyloxy-2,5-diaminobenzene, 1-pentadecyloxy-2,5-diaminobenzene, 1-hexadecyloxy-2, 5-diaminobenzene and 1-octadecyloxy-2,5-diaminobenzene are aromatic diamines represented by long-chain alkyl groups with 12 to 20 carbons; 1,3-bis(3 -aminopropyl)-tetramethyldisiloxane, 1,3-bis[3-(p-aminophenylaminoformyl)propyl]tetramethyldisiloxane, etc. have siloxane bonds Diamines; m-xylylenediamine, 1,3-propanediamine, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine, 1,3-bis(aminomethyl ) cyclohexane, 1,4-diaminocyclohexane, 4,4'-methylenebis(cyclohexylamine), formula (Y-1)~(Y- 167), diamine, etc., in which two amine groups are bonded to the group represented by any one of 167).
[化3] [Chem 3]
上述芳香族二胺(d)中,A表示2個一級胺基鍵結在芳香族基而得之1價基。芳香族基之具體例可列舉苯環、萘環、聯苯結構。X表示單鍵、-(CH 2) a-(a為1~15之整數。)、-CONH-、-NHCO-、-CO-N(CH 3)-、-NH-、-O-、-COO-、-CH=CH-COO-(CH 2) q-(q為1~18之整數。)、或-(A 1) a0-((CH 2) a1-A 1) m1-(a0為0或1之整數,a1為1~15之整數,A 1表示-O-或-COO-,A 1有多個時,各A 1各自獨立地具有上述定義。m1為1~2之整數。m1為2時,多個a1各自獨立地有上述定義。 In the above-mentioned aromatic diamine (d), A represents a monovalent group in which two primary amino groups are bonded to an aromatic group. Specific examples of the aromatic group include a benzene ring, a naphthalene ring, and a biphenyl structure. X represents a single bond, -(CH 2 ) a - (a is an integer from 1 to 15.), -CONH-, -NHCO-, -CO-N(CH 3 )-, -NH-, -O-, - COO-, -CH=CH-COO-(CH 2 ) q -(q is an integer from 1 to 18.), or -(A 1 ) a0 -((CH 2 ) a1 -A 1 ) m1 -(a0 is An integer of 0 or 1, a1 is an integer of 1 to 15 , A1 represents -O- or -COO-, and when there are multiple A1s, each A1 independently has the above definition. m1 is an integer of 1 to 2. When m1 is 2, a plurality of a1 each independently have the above-mentioned definition.
J表示具有選自由碳數4~40之脂環族烴基及碳數6~40之芳香族烴基構成之群組中之至少1種基之1價有機基。惟上述脂環族烴基及芳香族烴基擁有之氫原子之至少一個係被鹵素原子、含鹵素原子之烷基、含鹵素原子之烷氧基、碳數3~10之烷基、碳數3~10之烷氧基、碳數3~10之烯基取代,該等基中之任意亞甲基擁有之碳-碳鍵也可被-O-中斷。J represents a monovalent organic group having at least one group selected from the group consisting of an alicyclic hydrocarbon group having 4 to 40 carbon atoms and an aromatic hydrocarbon group having 6 to 40 carbon atoms. However, at least one of the hydrogen atoms possessed by the above-mentioned alicyclic hydrocarbon groups and aromatic hydrocarbon groups is replaced by a halogen atom, an alkyl group containing a halogen atom, an alkoxy group containing a halogen atom, an alkyl group having 3 to 10 carbon atoms, or an alkyl group having 3 to 10 carbon atoms. Substituted by an alkoxy group with 10 or an alkenyl group with 3 to 10 carbons, and the carbon-carbon bond possessed by any methylene group in these groups can also be interrupted by -O-.
又,J除了具有上述脂環族烴基及芳香族烴基以外,亦可更具有非取代或經上述取代基以外之取代基取代之選自由脂環族烴基及芳香族烴基構成之群組中之至少1種基。In addition, in addition to the above-mentioned alicyclic hydrocarbon group and aromatic hydrocarbon group, J may further have at least one selected from the group consisting of an alicyclic hydrocarbon group and an aromatic hydrocarbon group that is unsubstituted or substituted with a substituent other than the above-mentioned substituents. 1 base.
含鹵素原子之烷基,例如:碳數1~10之含鹵素原子之烷基。An alkyl group containing a halogen atom, for example: an alkyl group containing a halogen atom having 1 to 10 carbon atoms.
含鹵素原子之烷氧基,例如:碳數1~10之含鹵素原子之烷氧基。An alkoxy group containing a halogen atom, for example: an alkoxy group containing a halogen atom having 1 to 10 carbon atoms.
J之脂環族烴基可列舉環丁烷環、環戊烷環、環己烷環、環癸烷環、類固醇骨架(例如膽甾烷基、膽固醇基、羊毛甾烷基等)等,芳香族烴基可列舉苯環、萘環等。J具有環己烷環及苯環中之至少一者時,基「-X-J」例如:下列之結構(S1),更理想之結構可列舉下式(S1-1)~(S1-5)。The alicyclic hydrocarbon group of J includes cyclobutane ring, cyclopentane ring, cyclohexane ring, cyclodecane ring, steroid skeleton (such as cholestanyl group, cholesterol group, lanosteryl group, etc.), etc., aromatic Examples of the hydrocarbon group include a benzene ring, a naphthalene ring, and the like. When J has at least one of a cyclohexane ring and a benzene ring, the group "-X-J" is, for example, the following structure (S1), and more desirable structures include the following formulas (S1-1) to (S1-5).
[化4] [chemical 4]
上述(S1)中,X 1表示單鍵、-(CH 2) a-(a為1~15之整數。)、-CONH-、-CO-N(CH 3)-、-NH-、-O-、-COO-、-CH=CH-COO-(CH 2) q-(q為1~18之整數。)、或-(A 1) a0-((CH 2) a1-A 1) m1-(a0為0或1之整數,a1為1~15之整數,A 1表示-O-或-COO-,A 1有多個時,各A 1各自獨立地具有上述定義。m1為1~2之整數。m1為2時,多個a1各自獨立地有上述定義。 In the above (S1), X 1 represents a single bond, -(CH 2 ) a - (a is an integer of 1 to 15.), -CONH-, -CO-N(CH 3 )-, -NH-, -O -, -COO-, -CH=CH-COO-(CH 2 ) q -(q is an integer from 1 to 18.), or -(A 1 ) a0 -((CH 2 ) a1 -A 1 ) m1 - (a0 is an integer of 0 or 1, a1 is an integer of 1 to 15 , A1 represents -O- or -COO-, and when there are multiple A1s, each A1 independently has the above definition. m1 is 1 to 2 An integer of . When m1 is 2, a plurality of a1 each independently have the above definition.
G 1表示選自伸苯基、及伸環己基中之2價環狀基。前述環狀基上之任意氫原子亦可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子取代。 G 1 represents a divalent cyclic group selected from phenylene and cyclohexylene. Any hydrogen atom on the aforementioned cyclic group can also be replaced by an alkyl group with 1 to 3 carbons, an alkoxy group with 1 to 3 carbons, a fluorine-containing alkyl group with 1 to 3 carbons, or a fluorine-containing group with 1 to 3 carbons. Alkoxy or fluorine atom substitution.
m為1~4之整數。m為2以上時,多個X 1、G 1各自獨立地有上述定義。 m is an integer of 1-4. When m is 2 or more, a plurality of X 1 and G 1 each independently have the above-mentioned definitions.
R 1表示氟原子、碳數1~10之含氟原子之烷基、碳數1~10之含氟原子之烷氧基、碳數3~10之烷基、碳數3~10之烷氧基、或碳數3~10之烷氧基烷基。 R1 represents a fluorine atom, a fluorine-containing alkyl group with 1 to 10 carbons, an alkoxy group with 1 to 10 carbons, an alkyl group with 3 to 10 carbons, and an alkoxy group with 3 to 10 carbons group, or an alkoxyalkyl group with 3 to 10 carbon atoms.
[化5] [chemical 5]
X 1、R 1和上式(S1)之X 1、R 1為同義。 上述芳香族二胺(d)之具體例可列舉下式(d-1)~(d-2)表示之二胺。更理想的具體例,可列舉基「-X-J」為上述結構(S1)或為上式(S1-1)~(S1-5)中之任一者之式(d-1)~(d-2)表示之二胺、及膽甾烷基氧基-3,5-二胺基苯、膽甾烯基氧基-3,5-二胺基苯、膽甾烷基氧基-2,4-二胺基苯、3,5-二胺基苯甲酸膽甾烷酯、3,5-二胺基苯甲酸膽甾烯酯、3,5-二胺基苯甲酸羊毛甾烷酯及3,6-雙(4-胺基苯甲醯氧基)膽甾烷等具有類固醇骨架之二胺。上述基「-X-J」之X表示「-CH=CH-COO-(CH 2) q-」時,芳香族二胺(d)之更理想之具體例可列舉[4-[(E)-3-[2-(2,4-二胺基苯基)乙氧基]-3-側氧基-丙-1-烯基]苯基]4-(4,4,4-三氟丁氧基)苯甲酸酯、或[4-[(E)-3-[[5-胺基-2-[4-胺基-2-[[(E)-3-[4-[4-(4,4,4-三氟丁氧基)苯甲醯基]氧苯基]丙-2-烯醯基]氧甲基]苯基]苯基]甲氧基]-3-側氧基-丙-1-烯基]苯基]4-(4,4,4-三氟丁氧基)苯甲酸酯。 X 1 and R 1 are synonymous with X 1 and R 1 in the above formula (S1). Specific examples of the above-mentioned aromatic diamine (d) include diamines represented by the following formulas (d-1) to (d-2). More ideal specific examples include formulas (d-1) to (d- 2) The diamine represented, and cholestanyloxy-3,5-diaminobenzene, cholestanyloxy-3,5-diaminobenzene, cholestanyloxy-2,4 -diaminobenzene, 3,5-diaminobenzoic acid cholestyl ester, 3,5-diaminobenzoic acid cholestyl ester, 3,5-diaminobenzoic acid lanostyl ester and 3, Diamines having a steroid skeleton such as 6-bis(4-aminobenzoyloxy)cholestane. When X in the above-mentioned group "-XJ" represents "-CH=CH-COO-(CH 2 ) q -", more preferable specific examples of the aromatic diamine (d) include [4-[(E)-3 -[2-(2,4-diaminophenyl)ethoxy]-3-oxo-prop-1-enyl]phenyl]4-(4,4,4-trifluorobutoxy ) benzoate, or [4-[(E)-3-[[5-amino-2-[4-amino-2-[[(E)-3-[4-[4-(4 ,4,4-Trifluorobutoxy)benzoyl]oxyphenyl]prop-2-enyl]oxymethyl]phenyl]phenyl]methoxy]-3-oxo-propane -1-enyl]phenyl]4-(4,4,4-trifluorobutoxy)benzoate.
[化6] [chemical 6]
X、J和上述芳香族二胺(d)之X、J包括理想態樣在內為同義。前述式(d-2)中,2個X、J彼此可相同也可不同。 上述具有特定之含氮結構之二胺中之含氮雜環之理想具體例,可列舉吡咯、㗁唑、異㗁唑、吡咯啶、咪唑啶、哌啶、哌𠯤、 啶、𠰌啉、咪唑、吡唑、吡啶、嘧啶、嗒𠯤、吡𠯤、氮雜吲 、三唑、吲哚、苯并咪唑、咔唑等。 針對其他二胺,考量理想地獲得本發明之效果之觀點,宜為上述芳香族二胺(d)、對苯二胺、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2-雙(3-胺基苯基)六氟丙烷、2,2-雙(3-胺基-4-甲基苯基)六氟丙烷、2,2-雙(4-胺基苯基)丙烷、2,2-雙(3-胺基苯基)丙烷、2,2-雙(3-胺基-4-甲基苯基)丙烷、上述具有羧基之二胺、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基酮、2,2’-二甲基-4,4’-二胺基聯苯、4,4’-二胺基-2,2’-雙(三氟甲基)聯苯、上述具有光配向性基之二胺、具有自由基開始作用之二胺、末端具有光聚合性基之二胺、具有基「-N(D)-」之二胺、上述具有特定之含氮結構之二胺較佳。 X and J are synonymous with X and J of the said aromatic diamine (d) including an ideal form. In the aforementioned formula (d-2), two X and J may be the same as or different from each other. Ideal specific examples of the nitrogen-containing heterocycle in the above-mentioned diamine having a specific nitrogen-containing structure include pyrrole, oxazole, isoxazole, pyrrolidine, imidazolidine, piperidine, piperazole, Pyridine, 𠰌line, imidazole, pyrazole, pyridine, pyrimidine, pyridine, pyridine, azaind , triazole, indole, benzimidazole, carbazole, etc. For other diamines, considering the viewpoint of ideally obtaining the effect of the present invention, the above-mentioned aromatic diamine (d), p-phenylenediamine, 2,2-bis[4-(4-aminophenoxy)benzene base]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis (3-aminophenyl)hexafluoropropane, 2,2-bis(3-amino-4-methylphenyl)hexafluoropropane, 2,2-bis(4-aminophenyl)propane, 2 , 2-bis(3-aminophenyl)propane, 2,2-bis(3-amino-4-methylphenyl)propane, the above-mentioned diamines with carboxyl groups, 4,4'-diaminobis Phenylmethane, 4,4'-diaminodiphenylketone, 2,2'-dimethyl-4,4'-diaminobiphenyl, 4,4'-diamino-2,2' -Bis(trifluoromethyl)biphenyl, the above-mentioned diamines having a photoalignment group, diamines having a free radical initiation action, diamines having a photopolymerizable group at the end, and a group "-N(D)-" The diamines and the above-mentioned diamines with specific nitrogen-containing structures are preferred.
除了使用上述特定二胺以外更使用其他二胺時,上述其他二胺之使用量相對於全部二胺成分較佳為10~90莫耳%,更佳為20~80莫耳%。When other diamines are used in addition to the above-mentioned specific diamines, the usage-amount of the above-mentioned other diamines is preferably 10-90 mol %, more preferably 20-80 mol % with respect to the whole diamine component.
上述其他二胺之使用量相對於聚合物(P)之製造使用之全部二胺成分,較佳為10~90莫耳%,更佳為20~80莫耳%。 (四羧酸成分) 製造上述聚醯胺酸(P’)時,和二胺成分反應之四羧酸成分,不僅可使用四羧酸二酐,也可使用四羧酸、四羧醯二鹵化物、四羧酸二烷酯、或四羧酸二烷酯二鹵化物等四羧酸二酐之衍生物。 The usage-amount of the above-mentioned other diamine is preferably 10-90 mol %, more preferably 20-80 mol % with respect to the whole diamine component used for manufacture of a polymer (P). (tetracarboxylic acid component) When producing the above-mentioned polyamic acid (P'), the tetracarboxylic acid component reacted with the diamine component can use not only tetracarboxylic dianhydride, but also tetracarboxylic acid, tetracarboxylic acid dihalide, tetracarboxylic dihalide, and tetracarboxylic acid dihalide. Derivatives of tetracarboxylic dianhydrides such as alkyl esters and tetracarboxylic dialkyl dihalides.
本發明之聚合物(P)及聚醯胺酸(P’),係藉由含有芳香族四羧酸二酐或其衍生物(以下亦將它們總稱為芳香族四羧酸衍生物。)之四羧酸成分與二胺成分之聚合反應獲得。在此,芳香族四羧酸二酐,係指將包括芳香環所鍵結之至少1個羧基在內的4個羧基予以分子內脫水獲得之酸二酐。考量理想地獲得本發明之效果之觀點,上述芳香族四羧酸二酐或其衍生物,含有具有選自由苯環、及萘環構成之群組中之至少一種次結構之四羧酸二酐或該等之衍生物更佳。聚醯胺酸(P’)之合成能使用之四羧酸成分宜包括以下之芳香族四羧酸二酐或其衍生物(以下也將它們總稱為特定之芳香族四羧酸衍生物(b))。The polymer (P) and polyamic acid (P') of the present invention are obtained by containing aromatic tetracarboxylic dianhydride or derivatives thereof (hereinafter, they are also collectively referred to as aromatic tetracarboxylic acid derivatives.) It is obtained by the polymerization reaction of tetracarboxylic acid component and diamine component. Here, the aromatic tetracarboxylic dianhydride refers to an acid dianhydride obtained by intramolecularly dehydrating four carboxyl groups including at least one carboxyl group bonded to an aromatic ring. Considering the viewpoint of obtaining the effect of the present invention ideally, the above-mentioned aromatic tetracarboxylic dianhydride or its derivatives contain tetracarboxylic dianhydride having at least one substructure selected from the group consisting of benzene ring and naphthalene ring. Or derivatives thereof are more preferable. The tetracarboxylic acid components that can be used in the synthesis of polyamic acid (P') preferably include the following aromatic tetracarboxylic dianhydrides or derivatives thereof (hereinafter also collectively referred to as specific aromatic tetracarboxylic acid derivatives (b )).
又,上述芳香族四羧酸二酐或其衍生物可單獨使用一種也可將二種以上組合使用。Moreover, the said aromatic tetracarboxylic dianhydride or its derivative(s) may be used individually by 1 type, and may use it in combination of 2 or more types.
苯均四酸二酐、3,3’,4,4’-二苯基酮四羧酸二酐、3,3’,4,4’-聯苯碸四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3’,4,4’-聯苯醚四羧酸二酐、3,3’,4,4’-全氟異亞丙基二鄰苯二甲酸二酐、3,3’,4,4’-聯苯四羧酸二酐、2,2’,3,3’-聯苯四羧酸二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基丙烷二酐、乙二醇雙偏苯三甲酸酐、4,4’-(六氟異亞丙基)二鄰苯二甲酸酐、4,4’-羰基二鄰苯二甲酸酐、4,4’-氧基二(1,4-伸苯基)雙(鄰苯二甲酸)二酐、或4,4’-亞甲基二(1,4-伸苯基)雙(鄰苯二甲酸)二酐等芳香族四羧酸二酐;此外,日本特開2010-97188號公報記載之芳香族四羧酸二酐等。pyromellitic dianhydride, 3,3',4,4'-diphenyl ketone tetracarboxylic dianhydride, 3,3',4,4'-biphenyl tetracarboxylic dianhydride, 1,4, 5,8-naphthalene tetracarboxylic dianhydride, 2,3,6,7-naphthalene tetracarboxylic dianhydride, 3,3',4,4'-diphenyl ether tetracarboxylic dianhydride, 3,3', 4,4'-Perfluoroisopropylidene diphthalic dianhydride, 3,3',4,4'-biphenyltetracarboxylic dianhydride, 2,2',3,3'-biphenyltetra Carboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride, ethylene glycol bis-trimellitic anhydride, 4,4'-(hexafluoroisopropylidene ) diphthalic anhydride, 4,4'-carbonyl diphthalic anhydride, 4,4'-oxybis(1,4-phenylene)bis(phthalic acid)dianhydride, or 4 , 4'-methylene bis(1,4-phenylene) bis(phthalic acid) dianhydride and other aromatic tetracarboxylic dianhydrides; Carboxylic acid dianhydride, etc.
上述特定之芳香族四羧酸衍生物(b)之理想例,可列舉苯均四酸二酐、3,3’,4,4’-二苯基酮四羧酸二酐、3,3’,4,4’-聯苯碸四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3’,4,4’-聯苯醚四羧酸二酐、3,3’,4,4’-聯苯四羧酸二酐、2,2’,3,3’-聯苯四羧酸二酐、或該等之衍生物。Ideal examples of the above specific aromatic tetracarboxylic acid derivatives (b) include pyromellitic dianhydride, 3,3',4,4'-diphenone tetracarboxylic dianhydride, 3,3' ,4,4'-Biphenyl tetracarboxylic dianhydride, 1,4,5,8-naphthalene tetracarboxylic dianhydride, 2,3,6,7-naphthalene tetracarboxylic dianhydride, 3,3', 4,4'-Diphenyl ether tetracarboxylic dianhydride, 3,3',4,4'-Biphenyl tetracarboxylic dianhydride, 2,2',3,3'-Biphenyl tetracarboxylic dianhydride, or derivatives thereof.
上述芳香族四羧酸衍生物(更佳為特定之芳香族四羧酸衍生物(b))之使用比例,相對於使用之全部四羧酸成分1莫耳為10莫耳%以上較理想,20莫耳%以上更佳,50莫耳%以上又更佳。 上述聚醯胺酸(P’)之製造使用的四羧酸成分亦可含有芳香族四羧酸衍生物以外之四羧酸衍生物(以下亦稱為其他四羧酸衍生物。)。上述芳香族四羧酸衍生物以外更併用其他四羧酸衍生物時,芳香族四羧酸衍生物相對於四羧酸成分之使用量為90莫耳%以下較理想,80莫耳%以下更理想。以下列舉其他四羧酸衍生物之例,但本發明不限於此等。上述其他四羧酸衍生物可單獨使用一種也可將二種以上組合使用。 The usage ratio of the above-mentioned aromatic tetracarboxylic acid derivatives (more preferably the specific aromatic tetracarboxylic acid derivatives (b)) is more than 10 mol% relative to 1 mol of all the tetracarboxylic acid components used. More preferably 20 mole % or more, more preferably 50 mole % or more. The tetracarboxylic acid component used in the production of the polyamic acid (P') may contain tetracarboxylic acid derivatives other than aromatic tetracarboxylic acid derivatives (hereinafter also referred to as other tetracarboxylic acid derivatives.). When using other tetracarboxylic acid derivatives in addition to the above-mentioned aromatic tetracarboxylic acid derivatives, the amount of aromatic tetracarboxylic acid derivatives relative to the tetracarboxylic acid component is preferably 90 mole % or less, more preferably 80 mole % or less. ideal. Examples of other tetracarboxylic acid derivatives are listed below, but the present invention is not limited thereto. The above-mentioned other tetracarboxylic acid derivatives may be used alone or in combination of two or more.
上述其他四羧酸衍生物可列舉非環族脂肪族四羧酸二酐、脂環族四羧酸二酐或該等之衍生物。在此,非環族脂肪族四羧酸二酐,係將鏈狀烴結構所鍵結之4個羧基予以分子內脫水而獲得之酸二酐。惟無需僅由鏈狀烴結構構成,其一部分也可具有脂環族結構、芳香環結構。脂環族四羧酸二酐,係藉由將脂環族結構所鍵結之至少1個羧基在內的4個羧基予以分子內脫水而獲得之酸二酐。惟此等4個羧基皆不鍵結於芳香環。又,無需僅由脂環族結構構成,其一部分也可具有鏈狀烴結構、芳香環結構。脂環族四羧酸二酐,係藉由將脂環族結構所鍵結之至少1個羧基在內的4個羧基予以分子內脫水而獲得之酸二酐。惟此等4個羧基皆不鍵結於芳香環。又,無需僅由脂環族結構構成,其一部分也可具有鏈狀烴結構、芳香環結構。上述非環族脂肪族四羧酸二酐及脂環族四羧酸二酐可單獨使用一種也可將二種以上組合使用。Examples of the above-mentioned other tetracarboxylic acid derivatives include acyclic aliphatic tetracarboxylic dianhydride, alicyclic tetracarboxylic dianhydride, and derivatives thereof. Here, the acyclic aliphatic tetracarboxylic dianhydride is an acid dianhydride obtained by intramolecularly dehydrating four carboxyl groups bonded to a chain hydrocarbon structure. However, it does not need to be composed only of a chain hydrocarbon structure, and a part thereof may have an alicyclic structure or an aromatic ring structure. Alicyclic tetracarboxylic dianhydride is an acid dianhydride obtained by intramolecularly dehydrating four carboxyl groups including at least one carboxyl group bonded to an alicyclic structure. But these 4 carboxyl groups are not bonded to the aromatic ring. Moreover, it does not need to consist only of an alicyclic structure, and a part may have a chain hydrocarbon structure and an aromatic ring structure. Alicyclic tetracarboxylic dianhydride is an acid dianhydride obtained by intramolecularly dehydrating four carboxyl groups including at least one carboxyl group bonded to an alicyclic structure. But these 4 carboxyl groups are not bonded to the aromatic ring. Moreover, it does not need to consist only of an alicyclic structure, and a part may have a chain hydrocarbon structure and an aromatic ring structure. The above-mentioned acyclic aliphatic tetracarboxylic dianhydride and alicyclic tetracarboxylic dianhydride may be used alone or in combination of two or more.
考量理想地獲得本發明之效果之觀點,上述脂環族四羧酸二酐或該等之衍生物宜含有具有選自由環丁烷環結構、環戊烷環結構及環己烷環結構構成之群組中之至少一種次結構之四羧酸二酐或該等之衍生物更佳。Considering the viewpoint of obtaining the effects of the present invention ideally, the above-mentioned alicyclic tetracarboxylic dianhydride or derivatives thereof preferably contain a compound having a cyclobutane ring structure, a cyclopentane ring structure, and a cyclohexane ring structure. Tetracarboxylic dianhydrides of at least one substructure in the group or derivatives thereof are more preferred.
聚醯胺酸(P’)之合成能使用之其他四羧酸成分,較佳為包括以下之四羧酸二酐或該等之衍生物(以下亦將它們總稱為特定之脂肪族四羧酸衍生物(c))。 1,2,3,4-丁烷四羧酸二酐等非環族脂肪族四羧酸二酐;1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氯-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氟-1,2,3,4-環丁烷四羧酸二酐、1,3-雙(三氟甲基)-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、3,3’,4,4’-二環己基四羧酸二酐、2,3,5-三羧基環戊基乙酸二酐、4-(2,5-二側氧基四氫呋喃-3-基)四氫萘-1,2-二羧酸二酐、5-(2,5-二側氧基四氫呋喃-3-基)-3a,4,5,9b-四氫萘并[1,2-c]呋喃-1,3-二酮、5-(2,5-二側氧基四氫呋喃-3-基)-8-甲基-3a,4,5,9b-四氫萘并[1,2-c]呋喃-1,3-二酮、雙環[2.2.2]辛-7-烯-2,3,5,6-四羧酸二酐、雙環[2.2.2]辛烷-2,3,5,6-四羧酸二酐、2,4,6,8-四羧基雙環[3.3.0]辛烷-2:4,6:8-二酐等脂環族四羧酸二酐;此外,日本特開2010-97188號公報記載之四羧酸二酐等。 Other tetracarboxylic acid components that can be used in the synthesis of polyamic acid (P') preferably include the following tetracarboxylic dianhydrides or their derivatives (hereinafter also collectively referred to as specific aliphatic tetracarboxylic acids derivative (c)). 1,2,3,4-butanetetracarboxylic dianhydride and other acyclic aliphatic tetracarboxylic dianhydrides; 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl -1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dichloro -1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3 -Difluoro-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-bis(trifluoromethyl)-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-Cyclopentanetetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic acid Dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, 4-(2,5-dipentoxytetrahydrofuran-3-yl)tetrahydronaphthalene-1,2-dicarboxylic dianhydride, 5 -(2,5-Dioxotetrahydrofuran-3-yl)-3a,4,5,9b-tetrahydronaphtho[1,2-c]furan-1,3-dione, 5-(2, 5-Dioxotetrahydrofuran-3-yl)-8-methyl-3a,4,5,9b-tetrahydronaphtho[1,2-c]furan-1,3-dione, bicyclo[2.2. 2] Oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, bicyclo[2.2.2]octane-2,3,5,6-tetracarboxylic dianhydride, 2,4,6 , 8-tetracarboxybicyclo[3.3.0]octane-2:4,6:8-dianhydride and other alicyclic tetracarboxylic dianhydrides; anhydride, etc.
上述特定之脂肪族四羧酸衍生物(c)之理想例可列舉1,2,3,4-丁烷四羧酸二酐、1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氟-1,2,3,4-環丁烷四羧酸二酐、1,3-雙(三氟甲基)-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、3,3’,4,4’-二環己基四羧酸二酐、2,3,5-三羧基環戊基乙酸二酐、5-(2,5-二側氧基四氫呋喃-3-基)-3a,4,5,9b-四氫萘并[1,2-c]呋喃-1,3-二酮、5-(2,5-二側氧基四氫呋喃-3-基)-8-甲基-3a,4,5,9b-四氫萘并[1,2-c]呋喃-1,3-二酮、2,4,6,8-四羧基雙環[3.3.0]辛烷-2:4,6:8-二酐或該等之衍生物。Ideal examples of the aforementioned specific aliphatic tetracarboxylic acid derivatives (c) include 1,2,3,4-butane tetracarboxylic dianhydride, 1,2,3,4-cyclobutane tetracarboxylic dianhydride , 1,2-Dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride , 1,2,3,4-tetramethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-difluoro-1,2,3,4-cyclobutane tetracarboxylic Acid dianhydride, 1,3-bis(trifluoromethyl)-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride , 5-(2,5-dioxotetrahydrofuran-3-yl)-3a,4,5,9b-tetrahydronaphtho[1,2-c]furan-1,3-dione, 5-( 2,5-Dioxotetrahydrofuran-3-yl)-8-methyl-3a,4,5,9b-tetrahydronaphtho[1,2-c]furan-1,3-dione, 2, 4,6,8-tetracarboxybicyclo[3.3.0]octane-2:4,6:8-dianhydride or derivatives thereof.
(聚醯胺酸之合成) 聚醯胺酸之合成,係藉由使含有上述特定二胺之二胺成分、與含有上述芳香族四羧酸二酐或其衍生物之四羧酸衍生物成分於有機溶劑中反應以進行。供應聚醯胺酸之合成反應之四羧酸二酐與二胺之使用比例,宜為相對於二胺之胺基1當量,四羧酸二酐之酸酐基成為0.5~2當量之比例較理想,更佳為成為0.8~1.2當量之比例。和通常的縮聚反應同樣,此四羧酸二酐之酸酐基之當量越接近1當量,則生成之聚醯胺酸之分子量變得越大。 (Synthesis of polyamide acid) The synthesis of polyamic acid is carried out by reacting the diamine component containing the above-mentioned specific diamine and the tetracarboxylic acid derivative component containing the above-mentioned aromatic tetracarboxylic dianhydride or its derivatives in an organic solvent. The proportion of tetracarboxylic dianhydride and diamine used in the synthesis reaction of polyamic acid is preferably 0.5-2 equivalents of anhydride groups of tetracarboxylic dianhydride relative to 1 equivalent of amine groups of diamine. , more preferably at a ratio of 0.8 to 1.2 equivalents. Similar to a general polycondensation reaction, the closer the equivalent of the acid anhydride group of the tetracarboxylic dianhydride is to 1 equivalent, the larger the molecular weight of the polyamic acid to be produced becomes.
聚醯胺酸之合成反應中,反應溫度為-20~150℃較理想,0~100℃更理想。又,反應時間為0.1~24小時較理想,0.5~12小時更理想。In the synthesis reaction of polyamic acid, the reaction temperature is preferably -20-150°C, more preferably 0-100°C. Also, the reaction time is preferably 0.1 to 24 hours, more preferably 0.5 to 12 hours.
聚醯胺酸之合成反應可於任意濃度進行,較佳為1~50質量%,更佳為5~30質量%。反應初期於高濃度進行,之後追加溶劑亦可。The synthesis reaction of polyamic acid can be carried out at any concentration, preferably 1-50% by mass, more preferably 5-30% by mass. The reaction may be carried out at a high concentration in the initial stage, and a solvent may be added thereafter.
上述有機溶劑之具體例可列舉環己酮、環戊酮、N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、γ-丁內酯、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、二甲基亞碸、1,3-二甲基-2-咪唑啶酮。又,聚合物之溶劑溶解性高時,可使用甲乙酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮、丙二醇單甲醚、乙二醇單甲醚、乙二醇單乙醚、乙二醇單丙醚、二乙二醇單甲醚、或二乙二醇單乙醚。Specific examples of the aforementioned organic solvents include cyclohexanone, cyclopentanone, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, γ-butyrolactone, N,N-dimethylformamide , N,N-dimethylacetamide, dimethylsulfoxide, 1,3-dimethyl-2-imidazolidinone. Also, when the solvent solubility of the polymer is high, methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone, propylene glycol monomethyl ether, ethylene glycol monomethyl ether, ethyl Glycol monoethyl ether, ethylene glycol monopropyl ether, diethylene glycol monomethyl ether, or diethylene glycol monoethyl ether.
(聚醯胺酸酯之合成) 聚醯胺酸酯,例如可利用下列既知之方法獲得:[I]使上述方法獲得之聚醯胺酸與酯化劑反應之方法、[II]使四羧酸二酯與二胺反應之方法、[III]使四羧酸二酯二鹵化物與二胺反應之方法等。 (Synthesis of polyamide ester) Polyamic acid esters can be obtained, for example, by the following known methods: [I] a method of reacting the polyamic acid obtained by the above method with an esterifying agent, [II] a method of reacting a tetracarboxylic acid diester with a diamine , [III] A method of reacting a tetracarboxylic acid diester dihalide with a diamine, etc.
(聚醯亞胺之合成) 此外,可藉由將上述聚醯胺酸或聚醯胺酸酯等聚醯亞胺前驅物予以閉環(醯亞胺化),以獲得聚醯亞胺。此外,本說明書所指之醯亞胺化率,係指醯亞胺基在來自四羧酸二酐或其衍生物之醯亞胺基與羧基(或其衍生物)之合計量所占之比例。醯亞胺化率無需一定要為100%,可因應用途、目的而任意調整。 (Synthesis of Polyimide) In addition, the polyimide can be obtained by ring-closing (imidizing) the polyimide precursors such as the above-mentioned polyamic acid or polyamic acid ester. In addition, the imidization rate referred to in this specification refers to the ratio of imide groups to the total amount of imide groups and carboxyl groups (or derivatives thereof) derived from tetracarboxylic dianhydride or its derivatives. . The imidization rate does not necessarily have to be 100%, and can be adjusted arbitrarily according to the application and purpose.
將聚醯亞胺前驅物予以醯亞胺化之方法,可列舉將聚醯亞胺前驅物之溶液直接加熱之熱醯亞胺化或於聚醯亞胺前驅物之溶液添加觸媒之觸媒醯亞胺化。The method of imidizing the polyimide precursor may include thermal imidization by directly heating the solution of the polyimide precursor or adding a catalyst to the solution of the polyimide precursor imidization.
使聚醯亞胺前驅物在溶液中進行熱醯亞胺化時之溫度,通常為100~400℃,較佳為120~250℃,宜邊將因醯亞胺化反應生成之水排出到系外邊進行較佳。The temperature when the polyimide precursor is thermally imidized in the solution is usually 100-400°C, preferably 120-250°C. It is advisable to discharge the water generated by the imidization reaction to the system It is better to do it outside.
聚醯亞胺前驅物之觸媒醯亞胺化,可藉由於聚醯亞胺前驅物之溶液中添加鹼性觸媒及酸酐,較佳為於-20~250℃,更佳為0~180℃攪拌以進行。鹼性觸媒之量較佳為醯胺酸基之0.5~30莫耳倍,更佳為2~20莫耳倍,酸酐之量較佳為醯胺酸基之1~50莫耳倍,更佳為3~30莫耳倍。鹼性觸媒可列舉吡啶、三乙胺、三甲胺、三丁胺或三辛胺等,其中吡啶帶有使反應進行之適度鹼性,故更理想。酸酐可列舉乙酸酐、偏苯三甲酸酐、或苯均四酸酐等,其中若使用乙酸酐,則反應結束後之精製變得容易,較為理想。利用觸媒醯亞胺化所致之醯亞胺化率,可利用觸媒量及反應溫度、反應時間之調節予以控制。Catalyzed imidization of polyimide precursor can be achieved by adding alkaline catalyst and acid anhydride to the solution of polyimide precursor, preferably at -20 ~ 250 ° C, more preferably at 0 ~ 180 °C for stirring. The amount of alkaline catalyst is preferably 0.5-30 mole times of amide acid group, more preferably 2-20 mole times, and the amount of acid anhydride is preferably 1-50 mole times of amide acid group, more preferably Preferably it is 3-30 mole times. Examples of basic catalysts include pyridine, triethylamine, trimethylamine, tributylamine, and trioctylamine. Among them, pyridine is more ideal because it has a moderate alkalinity for the reaction to proceed. Examples of the acid anhydride include acetic anhydride, trimellitic anhydride, or pyromellitic anhydride. Among them, acetic anhydride is preferred because it facilitates purification after the reaction. The imidization rate caused by imidization using a catalyst can be controlled by adjusting the amount of catalyst, reaction temperature, and reaction time.
當從聚醯亞胺前驅物或聚醯亞胺之反應溶液回收生成之聚醯亞胺前驅物或聚醯亞胺時,將反應溶液投入到溶劑並使其沉澱即可。沉澱使用之溶劑可列舉甲醇、乙醇、異丙醇、丙酮、己烷、丁基賽珞蘇、庚烷、甲乙酮、甲基異丁基酮、甲苯、苯、水等。投入到溶劑而使其沉澱之聚合物,當過濾回收後,可於常壓或減壓下,於常溫乾燥或加熱乾燥。又,使沉澱回收之聚合物再溶於有機溶劑並進行再沉澱回收,此操作若重複2~10次則能減少聚合物中之雜質。此時之溶劑例如:醇類、酮類或烴等,若使用該等中選出之3種以上之溶劑,則精製之效率更好,故為理想。When recovering the produced polyimide precursor or polyimide from the polyimide precursor or polyimide reaction solution, the reaction solution may be poured into a solvent and precipitated. Solvents used for precipitation include methanol, ethanol, isopropanol, acetone, hexane, butylcytosol, heptane, methyl ethyl ketone, methyl isobutyl ketone, toluene, benzene, water and the like. The polymer that has been thrown into a solvent to precipitate can be dried at normal temperature or heated under normal pressure or reduced pressure after being collected by filtration. In addition, the polymer recovered by precipitation is redissolved in an organic solvent and recovered by reprecipitation. If this operation is repeated 2 to 10 times, the impurities in the polymer can be reduced. The solvents at this time are, for example, alcohols, ketones, or hydrocarbons. If three or more solvents selected from these are used, the purification efficiency will be better, so it is ideal.
<封端劑> 本發明中,合成聚醯亞胺前驅物、聚醯亞胺時,使用含有四羧酸二酐或其衍生物之四羧酸成分、及含有上述特定二胺之二胺成分,並使用適當的封端劑來合成末端密封型之聚合物亦可。末端密封型之聚合物,具有使利用塗膜獲得之液晶配向膜之膜硬度提升、使密封劑與配向膜之密合性提升之效果。 <Blocking agent> In the present invention, when synthesizing polyimide precursors and polyimides, tetracarboxylic acid components containing tetracarboxylic dianhydride or derivatives thereof, and diamine components containing the above-mentioned specific diamines are used, and appropriate End-capping agent can also be used to synthesize end-sealed polymers. End-sealed polymers have the effect of increasing the film hardness of the liquid crystal alignment film obtained by using the coating film, and improving the adhesion between the sealant and the alignment film.
本發明中,聚醯亞胺前驅物、聚醯亞胺之末端之例可列舉胺基、羧基、酸酐基或來自後述封端劑之基。胺基、羧基、酸酐基可利用通常之縮合反應獲得、或可藉由使用以下之封端劑來封閉末端以獲得。In the present invention, examples of the terminal of the polyimide precursor and polyimide include an amine group, a carboxyl group, an acid anhydride group, or a group derived from a terminal blocking agent described later. Amino groups, carboxyl groups, and acid anhydride groups can be obtained by a common condensation reaction, or can be obtained by blocking the ends with the following blocking agents.
封端劑,例如乙酸酐、馬來酸酐、奈地酸酐、鄰苯二甲酸酐、衣康酸酐、環己烷二羧酸酐、3-羥基鄰苯二甲酸酐、偏苯三甲酸酐、3-(3-三甲氧基矽基)丙基)-3,4-二氫呋喃-2,5-二酮、4,5,6,7-四氟異苯并呋喃-1,3-二酮、4-乙炔基鄰苯二甲酸酐等酸酐;二碳酸二第三丁酯、二碳酸二烯丙酯等二碳酸二酯化合物;丙烯醯氯、甲基丙烯醯氯、菸鹼醯氯等氯羰基化合物;苯胺、2-胺基苯酚、3-胺基苯酚、4-胺基水楊酸、5-胺基水楊酸、6-胺基水楊酸、2-胺基苯甲酸、3-胺基苯甲酸、4-胺基苯甲酸、環己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺等單胺化合物;乙基異氰酸酯、苯基異氰酸酯、萘基異氰酸酯、或異氰酸2-丙烯醯氧基乙酯及異氰酸2-甲基丙烯醯氧乙酯等具有不飽和鍵之異氰酸酯等。Capping agents such as acetic anhydride, maleic anhydride, nedylic anhydride, phthalic anhydride, itaconic anhydride, cyclohexanedicarboxylic anhydride, 3-hydroxyphthalic anhydride, trimellitic anhydride, 3-( 3-trimethoxysilyl)propyl)-3,4-dihydrofuran-2,5-dione, 4,5,6,7-tetrafluoroisobenzofuran-1,3-dione, 4 -Acid anhydrides such as ethynyl phthalic anhydride; Dicarbonate diester compounds such as di-tert-butyl dicarbonate and diallyl dicarbonate; Chlorocarbonyl compounds such as acryl chloride, methacryl chloride, and nicotinyl chloride ;Aniline, 2-aminophenol, 3-aminophenol, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzoic acid, 3-aminosalicylic acid Benzoic acid, 4-aminobenzoic acid, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine and other monoamine compounds; ethyl isocyanate, phenyl isocyanate, naphthyl isocyanate, or Isocyanates having unsaturated bonds, such as 2-acryloxyethyl isocyanate and 2-methacryloxyethyl isocyanate, etc.
封端劑之使用比例,相對於使用之二胺成分之合計100莫耳份為0.01~20莫耳份佳,0.01~10莫耳份更佳。The usage ratio of the end-capping agent is preferably 0.01-20 mole parts, more preferably 0.01-10 mole parts, relative to the total 100 mole parts of the diamine components used.
聚醯亞胺前驅物及聚醯亞胺之利用凝膠滲透層析(GPC)測得之聚苯乙烯換算之重量平均分子量(Mw)較佳為1,000~500,000,更佳為2,000~300,000。又,以Mw與利用GPC測得之聚苯乙烯換算之數量平均分子量(Mn)之比表示之分子量分布(Mw/Mn),較佳為15以下,更佳為10以下。藉由為此分子量範圍內,能確保液晶顯示元件之良好配向性。The polyimide precursor and the polyimide have a polystyrene-equivalent weight average molecular weight (Mw) measured by gel permeation chromatography (GPC), preferably from 1,000 to 500,000, more preferably from 2,000 to 300,000. Also, the molecular weight distribution (Mw/Mn) represented by the ratio of Mw to the polystyrene-equivalent number average molecular weight (Mn) measured by GPC is preferably 15 or less, more preferably 10 or less. By being within this molecular weight range, good alignment of liquid crystal display elements can be ensured.
本發明之液晶配向劑含有上述具有2個以上之交聯性基之化合物(以下也稱為特定之含交聯性基之化合物。)。 交聯性基,係可藉由光、熱而於相同或相異之分子間形成共價鍵之基,若為能和聚合物(P)反應之化合物則無特殊限制。交聯性基之具體例,例如聚合性不飽和鍵基、環氧乙烷基、氧雜環丁烷基、㗁唑啉基、保護異氰酸酯基、環碳酸酯基、β-羥基烷基醯胺基、米氏酸(Meldrum’s acid)基、羥甲基、或甲氧基甲基等。考量理想地獲得本發明之效果之觀點,該等之中,具有羥基之交聯性基較理想,β-羥基烷基醯胺基、或羥甲基為較佳。 藉由使用具有羥基之交聯性基,不僅交聯性化合物與聚合物(P)交聯,交聯性化合物彼此也能自交聯,獲得之液晶配向膜具有高電壓保持率。上述特定之交聯性化合物,考量使交聯反應容易之觀點,其分子量為2000以下更佳,200~1800更佳,200~1500更理想。 特定之含交聯性基之化合物擁有之交聯性基之數目,考量理想地獲得本發明之效果之觀點,為2~6個較理想,4~6個更理想。 又,交聯性基為β-羥基烷基醯胺基時,特定之含交聯性基之化合物中含有1個β-羥基烷基時,交聯性基之數目訂為1個,β-羥基烷基在特定之含交聯性基之化合物中含有2~6個時,則交聯性基之數目訂為2~6個。 上述聚合性不飽和鍵基可列舉(甲基)丙烯醯基、乙烯基苯基、乙烯氧基(CH 2=CH-O-)、烯丙基、馬來醯亞胺基等。又,「(甲基)丙烯醯基」,係包括丙烯醯基及甲基丙烯醯基之含意。 特定之含交聯性基之化合物之理想具體例可列舉下列化合物。特定之含交聯性基之化合物可單獨使用一種也可將二種以上組合使用。 具有聚合性不飽和鍵基之化合物可列舉甘油二(甲基)丙烯酸酯(1,2-,1,3-體混合物)、甘油參(甲基)丙烯酸酯、甘油1,3-二甘油二(甲基)丙烯酸酯、新戊四醇三(甲基)丙烯酸酯、二乙二醇二(甲基)丙烯酸酯、三乙二醇二(甲基)丙烯酸酯、四乙二醇二(甲基)丙烯酸酯、五乙二醇二(甲基)丙烯酸酯、六乙二醇二(甲基)丙烯酸酯; 具有環氧乙烷基之化合物可列舉N,N,N’,N’-四環氧丙基-1,4-苯二胺、N,N,N’,N’-四環氧丙基-2,2’-二甲基-4.4’-二胺基聯苯、2,2-雙[4-(N,N-二環氧丙基-4-胺基苯氧基)苯基]丙烷、N,N,N’,N’-四環氧丙基-4,4’-二胺基二苯基甲烷等三級氮原子和芳香族碳原子鍵結之化合物;N,N,N’,N’-四環氧丙基-1,2-二胺基環己烷、N,N,N’,N’-四環氧丙基-1,3-二胺基環己烷、N,N,N’,N’-四環氧丙基-1,4-二胺基環己烷、雙(N,N-二環氧丙基-4-胺基環己基)甲烷、雙(N,N-二環氧丙基-2-甲基-4-胺基環己基)甲烷、雙(N,N-二環氧丙基-3-甲基-4-胺基環己基)甲烷、1,3-雙(N,N-二環氧丙胺基甲基)環己烷、1,4-雙(N,N-二環氧丙胺基甲基)環己烷、1,3-雙(N,N-二環氧丙胺基甲基)苯、1,4-雙(N,N-二環氧丙胺基甲基)苯、1,3,5-參(N,N-二環氧丙胺基甲基)環己烷、1,3,5-參(N,N-二環氧丙胺基甲基)苯等三級氮原子和脂肪族碳原子鍵結之化合物、TEPIC(日產化學公司製)等異氰尿酸三環氧丙酯等異氰尿酸酯化合物; 具有保護異氰酸酯基之化合物可列舉CORONATEAP Stable M、CORONATE2503、2515、2507、2513、2555、MILLIONATEMS-50(以上為東曹公司製)、TAKENATEB-830、B-815N、B-820NSU、B-842N、B-846N、B-870N、B-874N、B-882N(以上為三井化學公司製)等; 具有氧雜環丁烷基之化合物可列舉1,4-雙{[(3-乙基-3-氧雜環丁烷基)甲氧基]甲基}苯(ARONE OXETANE OXT-121(XDO))、二[2-(3-氧雜環丁烷基)丁基]醚(ARONE OXETANE OXT-221(DOX))、1,4-雙[(3-乙基氧雜環丁烷-3-基)甲氧基]苯(HQOX)、1,3-雙[(3-乙基氧雜環丁烷-3-基)甲氧基]苯(RSOX)、1,2-雙[(3-乙基氧雜環丁烷-3-基)甲氧基]苯(CTOX)、4,4’-雙[(3-乙基氧雜環丁烷-3-基)甲氧基]聯苯(4,4’-BPOX)、2,2’-雙[(3-乙基-3-氧雜環丁烷基)甲氧基]聯苯(2,2’-BPOX)、3,3’,5,5’-四甲基[4,4’-雙(3-乙基氧雜環丁烷-3-基)甲氧基]聯苯(TM-BPOX)、2,7-雙[(3-乙基氧雜環丁烷-3-基)甲氧基]萘(2,7-NpDOX)、1,6-雙[(3-乙基氧雜環丁烷-3-基)甲氧基]-2,2,3,3,4,4,5,5-八氟己烷(OFH-DOX)、2,4,6-O-參[(3-乙基氧雜環丁烷-3-基)甲基]三聚氰酸、雙酚A與3-乙基-3-氯甲基氧雜環丁烷(簡稱OXC)之醚化物(BisAOX)、雙酚F與OXC之醚化物(BisFOX)、苯酚酚醛清漆與OXC之醚化物(PNOX)、甲酚酚醛清漆與OXC之醚化物(CNOX)、氧雜環丁烷基倍半矽氧烷(OX-SQ)、3-乙基-3-羥基甲基氧雜環丁烷之矽烷氧化物(OX-SC)(以上括弧內為商品名或開發品名,東亞合成(股)製)、ETARNACOLL OXBP(宇部興產(股)製)以外,WO2011/132751號公報之段落[0170]~[0175]記載之具有2個以上之氧雜環丁烷基之化合物; 具有㗁唑啉基之化合物,可列舉2,2’-雙(2-㗁唑啉)、2,2’-雙(4-甲基-2-㗁唑啉)、2,2’-雙(5-甲基-2-㗁唑啉)、2,2’-雙(5,5-二甲基-2-㗁唑啉)、2,2’-雙(4,4-二甲基-2-㗁唑啉)、1,2-雙(2-㗁唑啉-2-基)乙烷、1,4-雙(2-㗁唑啉-2-基)丁烷、1,6-雙(2-㗁唑啉-2-基)己烷、1,8-雙(2-㗁唑啉-2-基)辛烷、1,4-雙(2-㗁唑啉-2-基)環己烷、1,2-雙(2-㗁唑啉-2-基)苯、1,3-雙(2-㗁唑啉-2-基)苯、1,4-雙(2-㗁唑啉-2-基)苯、1,2-雙(5-甲基-2㗁唑啉-2-基)苯、1,3-雙(5-甲基-2-㗁唑啉-2-基)苯、1,4-雙(5-甲基-2-㗁唑啉-2-基)苯、2,2’-對伸苯基雙(4,4’-二甲基-2-㗁唑啉)、1,4-雙(4,5-二氫-2-㗁唑基)苯、1,3-雙(4,5-二氫-2-㗁唑基)苯、2,3-雙(4-異丙烯基-2-㗁唑啉-2-基)丁烷、2,2’-雙(4-苄基-2-㗁唑啉)、2,6-雙(4-異丙基-2-㗁唑啉-2-基)吡啶、2,2’-異亞丙基雙(4-第三丁基-2-㗁唑啉)、2,2’-異亞丙基雙(4-苯基-2-㗁唑啉)、2,2’-亞甲基雙(4-第三丁基-2-㗁唑啉)、及2,2’-亞甲基雙(4-苯基-2-㗁唑啉)、1,2,4-參(2-㗁唑啉-2-基)苯等化合物、EPOCROS(商品名,日本觸媒(股)公司製)之類之具有㗁唑啉基之聚合物、寡聚物等化合物; 具有環碳酸酯基之化合物,可列舉N,N,N’,N’-肆[(2-側氧基-1,3-二氧戊環-4-基)甲基]-4,4’-二胺基二苯基甲烷、N,N’-雙[(2-側氧基-1,3-二氧戊環-4-基)甲基]-1,3-苯二胺; 具有β-羥基烷基醯胺基之化合物,可列舉下式(pL-1)~(pL-7)表示之具有鏈狀烴基或環狀基之化合物,更佳為N,N,N’,N’-肆(2-羥基乙基)己二醯胺; The liquid crystal alignment agent of the present invention contains the above-mentioned compound having two or more crosslinkable groups (hereinafter also referred to as a specific crosslinkable group-containing compound.). The crosslinking group is a group that can form a covalent bond between the same or different molecules by light or heat, and is not particularly limited as long as it is a compound that can react with the polymer (P). Specific examples of crosslinkable groups, such as polymerizable unsaturated bond group, oxirane group, oxetanyl group, oxazoline group, protected isocyanate group, cyclocarbonate group, β-hydroxyalkylamide group, Meldrum's acid group, hydroxymethyl group, or methoxymethyl group, etc. From the viewpoint of obtaining the effects of the present invention ideally, among these, a crosslinkable group having a hydroxyl group is preferable, and a β-hydroxyalkylamide group or a methylol group is preferable. By using a cross-linking group having a hydroxyl group, not only the cross-linking compound and the polymer (P) can be cross-linked, but also the cross-linking compounds can be self-cross-linked, and the obtained liquid crystal alignment film has a high voltage retention rate. The above-mentioned specific cross-linking compound has a molecular weight of 2000 or less, more preferably 200-1800, more preferably 200-1500, from the viewpoint of facilitating the cross-linking reaction. The number of crosslinking groups possessed by the specific crosslinking group-containing compound is preferably 2 to 6, more preferably 4 to 6, in view of obtaining the effect of the present invention. Also, when the cross-linking group is a β-hydroxyalkylamide group, when a specific cross-linking group-containing compound contains one β-hydroxyalkyl group, the number of the cross-linking group is 1, and the β- When 2 to 6 hydroxyalkyl groups are contained in a specific crosslinkable group-containing compound, the number of crosslinkable groups should be 2 to 6. Examples of the polymerizable unsaturated bond group include a (meth)acryl group, a vinylphenyl group, a vinyloxy group (CH 2 =CH—O—), an allyl group, and a maleimide group. Also, "(meth)acryl" means both acryl and methacryl. Desirable specific examples of the specific crosslinkable group-containing compound include the following compounds. The specific crosslinkable group-containing compound may be used alone or in combination of two or more. Compounds having polymerizable unsaturated bonds include glycerol di(meth)acrylate (1,2-,1,3-body mixture), glycerol ginseng (meth)acrylate, glycerol 1,3-diglycerol di (meth)acrylate, neopentylthritol tri(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, tetraethylene glycol di(meth)acrylate base) acrylate, pentaethylene glycol di(meth)acrylate, hexaethylene glycol di(meth)acrylate; compounds with oxirane groups include N,N,N',N'-tetra Epoxypropyl-1,4-phenylenediamine, N,N,N',N'-tetraepoxypropyl-2,2'-dimethyl-4.4'-diaminobiphenyl, 2,2 -Bis[4-(N,N-diepoxypropyl-4-aminophenoxy)phenyl]propane, N,N,N',N'-tetraepoxypropyl-4,4'- Compounds bonded by tertiary nitrogen atoms and aromatic carbon atoms such as diaminodiphenylmethane; N,N,N',N'-tetraepoxypropyl-1,2-diaminocyclohexane, N ,N,N',N'-tetraepoxypropyl-1,3-diaminocyclohexane, N,N,N',N'-tetraepoxypropyl-1,4-diaminocyclohexane Hexane, Bis(N,N-Diepoxypropyl-4-aminocyclohexyl)methane, Bis(N,N-Diepoxypropyl-2-methyl-4-aminocyclohexyl)methane, Bis(N,N-Diepoxypropyl-3-methyl-4-aminocyclohexyl)methane, 1,3-bis(N,N-Diepoxypropylaminomethyl)cyclohexane, 1, 4-bis(N,N-diecidylaminomethyl)cyclohexane, 1,3-bis(N,N-diecidylaminomethyl)benzene, 1,4-bis(N,N- Diglycidylaminomethyl) benzene, 1,3,5-paraffin (N,N-diepoxypropylaminomethyl)cyclohexane, 1,3,5-paraffin (N,N-diepoxypropylamine Compounds with tertiary nitrogen atoms bonded to aliphatic carbon atoms such as methyl) benzene, isocyanurate compounds such as triglycidyl isocyanurate such as TEPIC (manufactured by Nissan Chemical Co., Ltd.); compounds with protected isocyanate groups Examples include CORONATEAP Stable M, CORONATE2503, 2515, 2507, 2513, 2555, MILLIONATEMS-50 (manufactured by Tosoh Corporation), TAKENATE B-830, B-815N, B-820NSU, B-842N, B-846N, B- 870N, B-874N, B-882N (manufactured by Mitsui Chemicals Co., Ltd.), etc.; 1,4-bis{[(3-ethyl-3-oxetane is listed as a compound having an oxetanyl group) base)methoxy]methyl}benzene (ARONE OXETANE OXT-121(XDO)), bis[2-(3-oxetanyl)butyl]ether (ARONE OXETANE OXT-221(DOX)), 1,4-bis[(3-ethyloxetan-3-yl)methoxy]benzene (HQOX), 1,3-bis[(3-ethyloxetan-3-yl) )methoxy]benzene (RSOX), 1,2-bis[(3-ethyloxetan-3-yl)methoxy]benzene (CTOX), 4,4'-bis[(3- Ethyloxetan-3-yl)methoxy]biphenyl (4,4'-BPOX), 2,2'-bis[(3-ethyl-3-oxetanyl)methoxy Oxy]biphenyl (2,2'-BPOX), 3,3',5,5'-tetramethyl[4,4'-bis(3-ethyloxetan-3-yl)methanol Oxy]biphenyl (TM-BPOX), 2,7-bis[(3-ethyloxetan-3-yl)methoxy]naphthalene (2,7-NpDOX), 1,6-bis [(3-Ethyloxetan-3-yl)methoxy]-2,2,3,3,4,4,5,5-octafluorohexane (OFH-DOX), 2,4 ,6-O-reference [(3-ethyloxetane-3-yl)methyl]cyanuric acid, bisphenol A and 3-ethyl-3-chloromethyloxetane ( OXC) ether compound (BisAOX), bisphenol F and OXC ether compound (BisFOX), phenol novolac and OXC ether compound (PNOX), cresol novolak and OXC ether compound (CNOX), oxygen heterocycle Butyl silsesquioxane (OX-SQ), silane oxide of 3-ethyl-3-hydroxymethyloxetane (OX-SC) (the above brackets are trade names or product names under development, East Asia Compounds having two or more oxetanyl groups as described in paragraphs [0170] to [0175] of WO2011/132751, other than ETARNACOLL OXBP (manufactured by Ube Industries, Ltd.); Compounds having an oxazoline group include 2,2'-bis(2-oxazoline), 2,2'-bis(4-methyl-2-oxazoline), 2,2'-bis( 5-methyl-2-oxazoline), 2,2'-bis(5,5-dimethyl-2-oxazoline), 2,2'-bis(4,4-dimethyl-2 -oxazoline), 1,2-bis(2-oxazolin-2-yl)ethane, 1,4-bis(2-oxazolin-2-yl)butane, 1,6-bis( 2-oxazolin-2-yl)hexane, 1,8-bis(2-oxazolin-2-yl)octane, 1,4-bis(2-oxazolin-2-yl)cyclohexyl Alkane, 1,2-bis(2-oxazolin-2-yl)benzene, 1,3-bis(2-oxazolin-2-yl)benzene, 1,4-bis(2-oxazolin- 2-yl)benzene, 1,2-bis(5-methyl-2-oxazolin-2-yl)benzene, 1,3-bis(5-methyl-2-oxazolin-2-yl)benzene , 1,4-bis(5-methyl-2-oxazolin-2-yl)benzene, 2,2'-p-phenylenebis(4,4'-dimethyl-2-oxazolin) , 1,4-bis(4,5-dihydro-2-oxazolyl)benzene, 1,3-bis(4,5-dihydro-2-oxazolyl)benzene, 2,3-bis(4 -Isopropenyl-2-oxazolin-2-yl)butane, 2,2'-bis(4-benzyl-2-oxazoline), 2,6-bis(4-isopropyl-2 -oxazolin-2-yl)pyridine, 2,2'-isopropylidene bis(4-tert-butyl-2-oxazoline), 2,2'-isopropylidene bis(4-benzene base-2-oxazoline), 2,2'-methylenebis(4-tert-butyl-2-oxazoline), and 2,2'-methylenebis(4-phenyl-2 Compounds such as -oxazoline), 1,2,4-ginseng(2-oxazolin-2-yl)benzene, EPOCROS (trade name, manufactured by Nippon Shokubai Co., Ltd.) Compounds such as polymers and oligomers; compounds with cyclic carbonate groups, such as N,N,N',N'-tetra[(2-side oxy-1,3-dioxolane-4- Base)methyl]-4,4'-diaminodiphenylmethane, N,N'-bis[(2-oxo-1,3-dioxolan-4-yl)methyl]- 1,3-phenylenediamine; Compounds with β-hydroxyalkylamide groups, such as compounds with chain hydrocarbon groups or cyclic groups represented by the following formulas (pL-1) to (pL-7), are more preferred Is N,N,N',N'-tetra(2-hydroxyethyl)adipamide;
[化7] [chemical 7]
Q表示氫原子、碳數1~3之烷基、或*-C(R) 2-C(R’) 2-OH(R各自獨立地表示氫原子、碳數1~3之烷基、或*-CH 2-OH。R’各自獨立地表示氫原子、或碳數1~3之烷基),Q之至少2個表示*-C(R) 2-C(R’) 2-OH。多個Q可各自相同也可不同。m為1~8之整數。 L 31、L 33各自獨立地表示單鍵、-NR-(R表示氫原子或碳數1~6之烷基。)、-(CH 2) n-(n為1~6之整數。)、或*1-(CH 2) j-NR 31-(j為1~6之整數。R 31表示氫原子或碳數1~3之烷基。*1表示和羰基碳原子之原子鍵。),L 32表示單鍵、-NR 32-(R 32表示氫原子或碳數1~6之烷基。)、-(CH 2) k-(k為1~6之整數。)、-CH=CH-、-CONH-或-C(=O)-O-。n3為0~1之整數。 L 41、L 42、L 43、L 5各自獨立地表示單鍵、或-(CH 2) m-(m為1~6之整數。)。2個L 5可相同也可不同。) 具有米氏酸基之化合物可列舉下式(M L-1)表示之化合物; Q represents a hydrogen atom, an alkyl group with 1 to 3 carbons, or *-C(R) 2 -C(R') 2 -OH (R each independently represents a hydrogen atom, an alkyl group with 1 to 3 carbons, or *-CH 2 -OH. R' each independently represents a hydrogen atom or an alkyl group having 1 to 3 carbons), and at least two of Q represent *-C(R) 2 -C(R') 2 -OH. A plurality of Qs may be the same or different from each other. m is an integer of 1-8. L 31 and L 33 each independently represent a single bond, -NR- (R represents a hydrogen atom or an alkyl group having 1 to 6 carbons.), -(CH 2 ) n - (n is an integer of 1 to 6.), or *1-(CH 2 ) j -NR 31 -(j is an integer of 1 to 6. R 31 represents a hydrogen atom or an alkyl group with 1 to 3 carbons. *1 represents an atomic bond with a carbonyl carbon atom.), L 32 represents a single bond, -NR 32 - (R 32 represents a hydrogen atom or an alkyl group with 1 to 6 carbons.), -(CH 2 ) k - (k is an integer of 1 to 6.), -CH=CH -, -CONH-, or -C(=O)-O-. n3 is an integer of 0-1. L 41 , L 42 , L 43 , and L 5 each independently represent a single bond or -(CH 2 ) m - (m is an integer of 1 to 6.). The two L5s may be the same or different. ) Compounds having a Michaelis acid group can include compounds represented by the following formula ( ML -1);
[化8] [chemical 8]
R 1、R 2各自獨立地表示氫原子、或碳數1~5之1價有機基(較佳為碳數1~5之烷基、碳數2~5之烯基、碳數2~5之炔基)。G表示2價有機基,具體例可列舉從聚合物(P)之合成中使用的二胺取走了2個胺基之2價有機基。其中,從苯環等芳香族環鍵結了2個胺基之芳香族二胺取走了2個胺基之2價有機基為較佳。); 具有羥甲基或甲氧基甲基之化合物可列舉2,2-雙(4-羥基-3,5-二羥基甲基苯基)丙烷、2,2-雙(4-羥基-3,5-二甲氧基甲基苯基)丙烷、2,2-雙(4-羥基-3,5-二羥基甲基苯基)-1,1,1,3,3,3-六氟丙烷等苯酚性化合物、或下式(me-1)~(me-2)表示之化合物; R 1 and R 2 each independently represent a hydrogen atom, or a monovalent organic group with 1 to 5 carbons (preferably an alkyl group with 1 to 5 carbons, an alkenyl group with 2 to 5 carbons, or an alkenyl group with 2 to 5 carbons. alkynyl). G represents a divalent organic group, and a specific example thereof includes a divalent organic group obtained by removing two amine groups from diamine used in the synthesis of the polymer (P). Among them, an aromatic diamine having two amine groups bonded to an aromatic ring such as a benzene ring is preferable. ); Compounds with hydroxymethyl or methoxymethyl groups include 2,2-bis(4-hydroxyl-3,5-dihydroxymethylphenyl)propane, 2,2-bis(4-hydroxyl-3 ,5-dimethoxymethylphenyl)propane, 2,2-bis(4-hydroxy-3,5-dihydroxymethylphenyl)-1,1,1,3,3,3-hexafluoro Phenolic compounds such as propane, or compounds represented by the following formulas (me-1) to (me-2);
[化9] 2個R可相同也可不同。 [chemical 9] Two Rs may be the same or different.
本發明之液晶配向劑含有之特定之含交聯性基之化合物之含量,相對於 (A)成分之合計100質量份為0.1~30質量份較理想,更佳為0.1~20質量份,又更佳為1~10質量份。 (液晶配向劑) 本發明之液晶配向劑,係將(A)成分、(B)成分、及視需要使用之其他成分,較佳為分散或溶解在適當溶劑中而成之液狀組成物。 本發明之液晶配向劑中含有的聚合物之合計含量可因應欲形成之塗膜之厚度之設定適當變更,考量形成均勻且無缺陷之塗膜之觀點,1質量%以上較理想,考量溶液之保存安定性之觀點,10質量%以下為較佳。尤其理想的聚合物之合計含量為2~8質量%。 The content of the specific crosslinkable group-containing compound contained in the liquid crystal alignment agent of the present invention is preferably 0.1 to 30 parts by mass, more preferably 0.1 to 20 parts by mass, with respect to the total of 100 parts by mass of component (A), and More preferably, it is 1-10 mass parts. (Liquid Crystal Alignment Agent) The liquid crystal alignment agent of the present invention is preferably a liquid composition obtained by dispersing or dissolving component (A), component (B) and other components used as necessary in an appropriate solvent. The total content of the polymers contained in the liquid crystal alignment agent of the present invention can be appropriately changed according to the setting of the thickness of the coating film to be formed. In consideration of the viewpoint of forming a uniform and defect-free coating film, 1% by mass or more is ideal. Considering the thickness of the solution From the viewpoint of storage stability, 10% by mass or less is preferable. A particularly preferable total content of the polymers is 2 to 8% by mass.
本發明之液晶配向劑亦可含有(A)成分以外之其他聚合物(惟(B)成分除外)。若舉其他聚合物之具體例,可列舉選自下列所構成群組中之聚合物等:使用選自由符合(1)不使用含上述特定二胺之二胺成分、或(2)不使用含有芳香族四羧酸二酐或其衍生物之四羧酸成分中任一者或兩者之條件之單體成分獲得之聚醯亞胺前驅物及係該聚醯亞胺前驅物之醯亞胺化物的聚醯亞胺構成之群組中之至少1種聚合物(U)、聚矽氧烷、聚酯、聚醯胺、聚脲、聚有機矽氧烷、纖維素衍生物、聚縮醛、聚苯乙烯衍生物、聚(苯乙烯-馬來酸酐)共聚物、聚(異丁烯-馬來酸酐)共聚物、聚(乙烯醚-馬來酸酐)共聚物、聚(苯乙烯-苯基馬來醯亞胺)衍生物、聚(甲基)丙烯酸酯。針對前述聚合物(U),考量提高垂直配向性之觀點,可列舉選自由使用上述含有芳香族二胺(d)之二胺成分獲得之聚醯亞胺前驅物及該聚醯亞胺前驅物之醯亞胺化物構成之群組中之至少1種之聚合物。聚(苯乙烯-馬來酸酐)共聚物之具體例可列舉SMA1000、SMA2000、SMA3000(Cray Valley公司製)、GSM301(GIFUSHELLAC製造所公司製)等,聚(異丁烯-馬來酸酐)共聚物之具體例可列舉ISOBAM-600(可樂麗公司製),聚(乙烯醚-馬來酸酐)共聚物之具體例可列舉Gantrez AN-139(甲基乙烯醚馬來酸酐樹脂、ASHLAND公司製)。The liquid crystal alignment agent of the present invention may also contain other polymers other than component (A) (except component (B)). Specific examples of other polymers include polymers selected from the group consisting of: using a diamine component selected from (1) not using the above-mentioned specific diamine, or (2) not using a diamine containing A polyimide precursor obtained from the monomer component of either or both of the tetracarboxylic acid components of aromatic tetracarboxylic dianhydride or its derivatives and the imide that is the polyimide precursor At least one polymer (U) from the group consisting of polyimide, polysiloxane, polyester, polyamide, polyurea, polyorganosiloxane, cellulose derivative, polyacetal , polystyrene derivatives, poly(styrene-maleic anhydride) copolymers, poly(isobutylene-maleic anhydride) copolymers, poly(vinyl ether-maleic anhydride) copolymers, poly(styrene-phenylmaleic anhydride) copolymers, poly(styrene-phenylmaleic anhydride) copolymers imide) derivatives, poly(meth)acrylates. With respect to the aforementioned polymer (U), considering the viewpoint of improving the vertical alignment, examples include polyimide precursors obtained by using the diamine components containing the aromatic diamine (d) and the polyimide precursors. At least one polymer of the group consisting of imides. Specific examples of poly(styrene-maleic anhydride) copolymers include SMA1000, SMA2000, SMA3000 (manufactured by Cray Valley), GSM301 (manufactured by Gifu Shellac Manufacturing Co., Ltd.), and specific examples of poly(isobutylene-maleic anhydride) copolymers. Examples include ISOBAM-600 (manufactured by Kuraray Co., Ltd.), and specific examples of poly(vinyl ether-maleic anhydride) copolymers include Gantrez AN-139 (methyl vinyl ether maleic anhydride resin, manufactured by ASHLAND).
其他聚合物可單獨使用一種,也可將二種以上組合使用。其他聚合物之含有比例,相對於液晶配向劑中含有的聚合物之合計100質量份為90質量份以下較理想,10~90質量份更佳,20~80質量份更理想。The other polymers may be used alone or in combination of two or more. The content ratio of other polymers is preferably 90 parts by mass or less, more preferably 10 to 90 parts by mass, more preferably 20 to 80 parts by mass, based on the total of 100 parts by mass of the polymers contained in the liquid crystal alignment agent.
本發明之液晶配向劑也可視需要更含有上述以外之成分。該成分,例如:官能性矽烷化合物、金屬螯合物化合物、硬化促進劑、界面活性劑、抗氧化劑、增感劑、防腐劑、用於調整液晶配向膜之介電常數、電阻之化合物等。The liquid crystal alignment agent of the present invention may further contain components other than those mentioned above as required. Such components, for example: functional silane compounds, metal chelate compounds, hardening accelerators, surfactants, antioxidants, sensitizers, preservatives, compounds used to adjust the dielectric constant and resistance of liquid crystal alignment films, etc.
用於調整介電常數、電阻之化合物,可列舉3-吡啶甲基胺等具有含氮之芳香族雜環之單胺。使用具有含氮之芳香族雜環之單胺時,相對於液晶配向劑中含有的聚合物成分100質量份為0.1~30質量份較佳,更佳為0.1~20質量份。The compound used to adjust the dielectric constant and resistance includes monoamines having nitrogen-containing aromatic heterocycles such as 3-picolylamine. When using the monoamine which has a nitrogen-containing aromatic heterocycle, it is preferable that it is 0.1-30 mass parts with respect to 100 mass parts of polymer components contained in a liquid crystal alignment agent, and it is more preferable that it is 0.1-20 mass parts.
官能性矽烷化合物之理想具體例可列舉:3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-胺基丙基二乙氧基甲基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二甲氧基矽烷、3-環氧丙氧基丙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二乙氧基矽烷、3-環氧丙氧基丙基三乙氧基矽烷、對苯乙烯基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二乙氧基矽烷、3-甲基丙烯醯氧基丙基三乙氧基矽烷、3-丙烯醯氧基丙基三甲氧基矽烷、參[3-(三甲氧基矽基)丙基]異氰尿酸酯、3-巰基丙基甲基二甲氧基矽烷、3-巰基丙基三甲氧基矽烷、3-異氰酸酯丙基三乙氧基矽烷等。使用官能性矽烷化合物時,相對於液晶配向劑中含有的聚合物成分100質量份為0.1~30質量份較佳,更佳為0.1~20質量份。Ideal specific examples of functional silane compounds include: 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-aminopropyldiethoxymethylsilane, 2-aminopropyltrimethoxysilane, Aminopropyltrimethoxysilane, 2-aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-amino Ethyl)-3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, vinyltrimethoxysilane, vinyl Triethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 3-glycidoxypropyl Trimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 3-glycidoxypropyltriethoxysilane, p-styryltrimethoxysilane, 3-methoxysilane Acryloxypropylmethyldimethoxysilane, 3-methacryloxypropyltrimethoxysilane, 3-methacryloxypropylmethyldiethoxysilane, 3- Methacryloxypropyltriethoxysilane, 3-acryloxypropyltrimethoxysilane, ginseng[3-(trimethoxysilyl)propyl]isocyanurate, 3-mercapto Propylmethyldimethoxysilane, 3-mercaptopropyltrimethoxysilane, 3-isocyanatepropyltriethoxysilane, etc. When using a functional silane compound, it is preferable that it is 0.1-30 mass parts with respect to 100 mass parts of polymer components contained in a liquid crystal alignment agent, and it is more preferable that it is 0.1-20 mass parts.
本發明之液晶配向劑使用之有機溶劑,例如γ-戊內酯、γ-丁內酯等內酯溶劑;γ-丁內醯胺、N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、N-(正丙基)-2-吡咯烷酮、N-異丙基-2-吡咯烷酮、N-(正丁基)-2-吡咯烷酮、N-(第三丁基)-2-吡咯烷酮、N-(正戊基)-2-吡咯烷酮、N-甲氧基丙基-2-吡咯烷酮、N-乙氧基乙基-2-吡咯烷酮、N-甲氧基丁基-2-吡咯烷酮、N-環己基-2-吡咯烷酮等內醯胺溶劑;N,N-二甲基甲醯胺、N,N-二乙基甲醯胺、N,N-二甲基乙醯胺、N,N-二甲基丙醯胺、N,N-二乙基丙醯胺、N,N-二甲基乳醯胺、3-甲氧基-N,N-二甲基丙烷醯胺、3-丁氧基-N,N-二甲基丙烷醯胺、四甲基脲等醯胺溶劑;1,3-二甲基-2-咪唑啶酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮、乳酸丁酯、乙酸丁酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、3-甲氧基丙酸乙酯、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、乙二醇單甲醚、乙二醇單乙醚、乙二醇正丙醚、乙二醇異丙醚、乙二醇單丁醚(丁基賽珞蘇)、乙二醇二甲醚、乙二醇單丁醚乙酸酯、丙二醇單甲醚、丙二醇單丁醚、丙二醇二乙酸酯、二乙二醇二甲醚、二乙二醇二乙醚、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇單甲醚乙酸酯、二乙二醇單乙醚乙酸酯、二丙二醇單甲醚、二丙二醇二甲醚、二異丁基甲醇(2,6-二甲基-4-庚醇)、二異丁基酮、丙酸異戊酯、異丁酸異戊酯、二異戊醚、碳酸伸乙酯、碳酸伸丙酯等。可將它們中的2種以上混合使用。Organic solvents used in the liquid crystal alignment agent of the present invention, such as γ-valerolactone, γ-butyrolactone and other lactone solvents; γ-butyrolactam, N-methyl-2-pyrrolidone, N-ethyl-2 -pyrrolidone, N-(n-propyl)-2-pyrrolidone, N-isopropyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(tert-butyl)-2-pyrrolidone, N-(n-pentyl)-2-pyrrolidone, N-methoxypropyl-2-pyrrolidone, N-ethoxyethyl-2-pyrrolidone, N-methoxybutyl-2-pyrrolidone, N- Lactamide solvents such as cyclohexyl-2-pyrrolidone; N,N-dimethylformamide, N,N-diethylformamide, N,N-dimethylacetamide, N,N-di Methacrylamide, N,N-diethylacrylamide, N,N-dimethyllactamide, 3-methoxy-N,N-dimethylpropanamide, 3-butoxy -N,N-dimethylpropaneamide, tetramethylurea and other amide solvents; 1,3-dimethyl-2-imidazolidinone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methanone -2-pentanone, butyl lactate, butyl acetate, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-methoxy Propyl propionate, 3-methoxybutyl propionate, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol monobutyl ether (butyl Cellosu), ethylene glycol dimethyl ether, ethylene glycol monobutyl ether acetate, propylene glycol monomethyl ether, propylene glycol monobutyl ether, propylene glycol diacetate, diethylene glycol dimethyl ether, diethylene glycol Diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, dipropylene glycol monomethyl ether, dipropylene glycol dimethyl ether , diisobutylmethanol (2,6-dimethyl-4-heptanol), diisobutyl ketone, isoamyl propionate, isoamyl isobutyrate, diisoamyl ether, ethyl carbonate, Propylene carbonate, etc. These can be used in mixture of 2 or more types.
溶劑之理想的組合可列舉N-甲基-2-吡咯烷酮與乙二醇單丁醚、N-甲基-2-吡咯烷酮與γ-丁內酯與乙二醇單丁醚、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚、N-乙基-2-吡咯烷酮與丙二醇單丁醚、N-甲基-2-吡咯烷酮與γ-丁內酯與4-羥基-4-甲基-2-戊酮與二乙二醇二乙醚、N-乙基-2-吡咯烷酮與N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮、N-乙基-2-吡咯烷酮與N-甲基-2-吡咯烷酮與乙二醇單丁醚、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與2,6-二甲基-4-庚酮、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與二丙二醇單甲醚、N-乙基-2-吡咯烷酮與二丙二醇單甲醚與乙二醇單丁醚、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與丙二醇單丁醚、N-乙基-2-吡咯烷酮與N-甲基-2-吡咯烷酮與丙二醇單丁醚、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯、γ-丁內酯與4-羥基-4-甲基-2-戊酮與2,6-二甲基-4-庚酮、γ-丁內酯與4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚與2,6-二甲基-4-庚酮、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚與二異丙醚、N-甲基-2-吡咯烷酮與γ-丁內酯與丙二醇單丁醚與2,6-二甲基-4-庚醇、N-甲基-2-吡咯烷酮與γ-丁內酯與二丙二醇二甲醚、N-甲基-2-吡咯烷酮與丙二醇單丁醚與二丙二醇二甲醚、N-乙基-2-吡咯烷酮與丙二醇單丁醚與二丙二醇二甲醚、γ-丁內酯與乙二醇單丁醚與二丙二醇二甲醚、環己酮與乙二醇單丁醚、環己酮與丙二醇單丁醚、環己酮與丙二醇單甲醚、環戊酮與丙二醇單丁醚、環戊酮與丙二醇單甲醚、環己酮與二乙二醇單乙醚、環戊酮與二乙二醇單乙醚、環己酮與二異丁基酮、環戊酮與二異丁基酮、甲基異丁基酮與丙二醇單丁醚、甲乙酮與丙二醇單丁醚、環己酮與4-羥基-4-甲基-2-戊酮、環戊酮與4-羥基-4-甲基-2-戊酮、環己酮與二乙二醇二乙醚、環戊酮與二乙二醇二乙醚、四甲基脲與丙二醇二乙酸酯、N,N-二甲基丙醯胺與丙二醇單丁醚、四甲基脲與丙二醇單丁醚、四甲基脲與環己酮與丙二醇單甲醚、N,N-二甲基丙醯胺與丙二醇單甲醚、N,N-二甲基丙醯胺與乙二醇單丁醚乙酸酯、N,N-二甲基丙醯胺與乙二醇單丁醚、N,N-二乙基丙醯胺與丙二醇單甲醚、四甲基脲與丙二醇單甲醚、N,N-二甲基丙醯胺與環己酮與二乙二醇二乙醚、N,N-二乙基甲醯胺與丙二醇單甲醚、N,N-二乙基甲醯胺與4-羥基-4-甲基-2-戊酮、環己酮與乙酸正丁酯、環戊酮與乙酸正丁酯、4-羥基-4-甲基-2-戊酮與乙二醇單丁醚、環己酮與丙二醇二乙酸酯、及環戊酮與丙二醇二乙酸酯等。如此的溶劑的種類及含量,可因應液晶配向劑之塗佈裝置、塗佈條件、塗佈環境等予以適當選擇。The ideal combination of solvents can include N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone and ethylene glycol monobutyl ether, N-methyl-2- 2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone and 4-hydroxy-4- Methyl-2-pentanone and diethylene glycol diethyl ether, N-ethyl-2-pyrrolidone and N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone, N-ethyl Base-2-pyrrolidone and N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone and 2,6-di Methyl-4-heptanone, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone and dipropylene glycol monomethyl ether, N-ethyl-2-pyrrolidone and dipropylene glycol monomethyl ether Ether and ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone and propylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and N-methyl -2-pyrrolidone and propylene glycol monobutyl ether, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone and propylene glycol diacetate, γ-butyrolactone and 4-hydroxy-4 -Methyl-2-pentanone and 2,6-dimethyl-4-heptanone, γ-butyrolactone and 4-hydroxy-4-methyl-2-pentanone and propylene glycol diacetate, N- Methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether and 2,6-dimethyl-4-heptanone, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether With diisopropyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether with 2,6-dimethyl-4-heptanol, N-methyl-2-pyrrolidone and γ- Butyrolactone and dipropylene glycol dimethyl ether, N-methyl-2-pyrrolidone and propylene glycol monobutyl ether and dipropylene glycol dimethyl ether, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether and dipropylene glycol dimethyl ether, γ-butyrolactone and ethylene glycol monobutyl ether and dipropylene glycol dimethyl ether, cyclohexanone and ethylene glycol monobutyl ether, cyclohexanone and propylene glycol monobutyl ether, cyclohexanone and propylene glycol monomethyl ether, cyclopentyl Ketone and Propylene Glycol Monobutyl Ether, Cyclopentanone and Propylene Glycol Monomethyl Ether, Cyclohexanone and Diethylene Glycol Monoethyl Ether, Cyclopentanone and Diethylene Glycol Monoethyl Ether, Cyclohexanone and Diisobutyl Ketone, Cyclopentanone Ketone and diisobutyl ketone, methyl isobutyl ketone and propylene glycol monobutyl ether, methyl ethyl ketone and propylene glycol monobutyl ether, cyclohexanone and 4-hydroxy-4-methyl-2-pentanone, cyclopentanone and 4 -Hydroxy-4-methyl-2-pentanone, cyclohexanone and diethylene glycol diethyl ether, cyclopentanone and diethylene glycol diethyl ether, tetramethylurea and propylene glycol diacetate, N,N- Dimethylacrylamide and propylene glycol monobutyl ether, tetramethylurea and propylene glycol monobutyl ether, tetramethylurea and cyclohexanone and propylene glycol monomethyl ether, N,N-dimethylacrylamide and propylene glycol monomethyl ether Ether, N,N-dimethylacrylamide and ethylene glycol monobutyl ether acetate, N,N-dimethylacrylamide and ethylene glycol monobutyl ether, N,N-diethylacrylamide Amine and propylene glycol monomethyl ether, tetramethylurea and propylene glycol monomethyl ether, N,N-dimethylacrylamide and cyclohexanone and diethylene glycol diethyl ether, N,N-diethylformamide and Propylene glycol monomethyl ether, N,N-diethylformamide and 4-hydroxy-4-methyl-2-pentanone, cyclohexanone and n-butyl acetate, cyclopentanone and n-butyl acetate, 4- Hydroxy-4-methyl-2-pentanone and ethylene glycol monobutyl ether, cyclohexanone and propylene glycol diacetate, cyclopentanone and propylene glycol diacetate, etc. The type and content of such a solvent can be appropriately selected according to the coating device, coating conditions, and coating environment of the liquid crystal alignment agent.
液晶配向劑中之固體成分濃度(液晶配向劑之溶劑以外之成分之合計質量佔液晶配向劑之全部質量之比例),可考慮黏性、揮發性等而適當選擇,較佳為1~10質量%之範圍。考量形成均勻且無缺陷之塗膜之觀點,1質量%以上較理想,考量溶液之保存安定性之觀點,10質量%以下為較佳。尤其理想的聚合物之濃度為2~8質量%。 <液晶配向膜> 本發明之液晶配向膜係由上述液晶配向劑獲得。本發明之液晶配向膜,可使用於水平配向型或垂直配向型之液晶配向膜。垂直配向型之液晶配向膜中,VA方式或PSA(Polymer Sustained Alignment)方式等垂直配向型之液晶顯示元件使用之液晶配向膜為較佳。 <液晶顯示元件> 本發明之液晶配向劑具有上述液晶配向膜。本發明之液晶配向劑也宜在具備電極之一對基板間具有液晶層,並於一對基板間配置含有經活性能量射線及熱中之至少一者聚合之聚合性化合物的液晶組成物,經過邊對於電極間施加電壓邊進行活性能量射線之照射及加熱中之至少一者以使聚合性化合物聚合之步驟製造之液晶顯示元件中使用。 The solid content concentration in the liquid crystal alignment agent (the ratio of the total mass of the components other than the solvent of the liquid crystal alignment agent to the total mass of the liquid crystal alignment agent) can be appropriately selected in consideration of viscosity, volatility, etc., preferably 1 to 10 mass % range. From the viewpoint of forming a uniform and defect-free coating film, 1% by mass or more is preferable, and from the viewpoint of storage stability of the solution, 10% by mass or less is preferable. A particularly desirable concentration of the polymer is 2 to 8% by mass. <Liquid crystal alignment film> The liquid crystal alignment film of the present invention is obtained from the above-mentioned liquid crystal alignment agent. The liquid crystal alignment film of the present invention can be used in horizontal alignment type or vertical alignment type liquid crystal alignment film. Among the vertical alignment type liquid crystal alignment films, the liquid crystal alignment film used in vertical alignment type liquid crystal display elements such as VA method or PSA (Polymer Sustained Alignment) method is preferable. <Liquid crystal display elements> The liquid crystal alignment agent of the present invention has the above-mentioned liquid crystal alignment film. The liquid crystal alignment agent of the present invention also preferably has a liquid crystal layer between a pair of substrates with electrodes, and a liquid crystal composition containing a polymerizable compound polymerized by at least one of active energy rays and heat is disposed between the pair of substrates, and passes through the edge It is used in a liquid crystal display device manufactured in a step of polymerizing a polymerizable compound by at least one of irradiating an active energy ray and heating while applying a voltage between electrodes.
本發明之液晶顯示元件例如可利用依序進行以下之步驟(1)~(3)或步驟(1)~(4)之方法製造。 (1)將液晶配向劑塗佈在具有導電膜之一對基板中之至少一基板上而形成塗膜 在設有經圖案化之透明導電膜之一對基板中之至少一基板之一面,利用例如輥塗佈法、旋塗法、印刷法、噴墨法等適當塗佈方法塗佈本發明之液晶配向劑而製作塗膜。在此,基板只要是透明性高之基板即不特別限定,也可將玻璃基板、氮化矽基板和壓克力基板、聚碳酸酯基板等塑膠基板等一起使用。又,反射型之液晶顯示元件若僅是單側基板,則亦可使用矽晶圓等不透明物,此時之電極亦可使用鋁等會反射光之材料。 (2)將塗膜予以煅燒 液晶配向劑塗佈後,為了防止已塗佈之液晶配向劑之滴液,將上述塗膜予以煅燒。較佳為預先實施預備加熱(預烘)。預烘溫度較佳為30~200℃,更佳為40~150℃,尤佳為40~100℃。預烘時間較佳為0.25~10分,更佳為0.5~5分。並且宜實施加熱(後烘烤)步驟較佳。之後烘烤溫度較佳為80~300℃,更佳為120~250℃。後烘烤時間較佳為5~200分鐘,更佳為10~100分鐘。依此方式形成之膜之膜厚為5~300nm較理想,10~200nm更理想。 The liquid crystal display element of the present invention can be manufactured, for example, by a method of sequentially performing the following steps (1) to (3) or steps (1) to (4). (1) Coating a liquid crystal alignment agent on at least one of a pair of substrates having a conductive film to form a coating film On one side of at least one substrate of a pair of substrates provided with a patterned transparent conductive film, use an appropriate coating method such as roll coating method, spin coating method, printing method, inkjet method, etc. to coat the liquid crystal of the present invention Alignment agent to make coating film. Here, the substrate is not particularly limited as long as it is highly transparent, and a plastic substrate such as a glass substrate, a silicon nitride substrate, an acrylic substrate, or a polycarbonate substrate may be used together. In addition, if the reflective liquid crystal display element has only one side substrate, opaque objects such as silicon wafers can also be used, and the electrodes at this time can also use materials that reflect light such as aluminum. (2) Calcining the coating film After coating the liquid crystal alignment agent, in order to prevent the dripping of the coated liquid crystal alignment agent, the above-mentioned coating film is calcined. Preliminary heating (prebaking) is preferably carried out in advance. The pre-baking temperature is preferably 30-200°C, more preferably 40-150°C, especially preferably 40-100°C. The pre-baking time is preferably from 0.25 to 10 minutes, more preferably from 0.5 to 5 minutes. And it is better to implement a heating (post-baking) step. The subsequent baking temperature is preferably 80-300°C, more preferably 120-250°C. The post-baking time is preferably from 5 to 200 minutes, more preferably from 10 to 100 minutes. The thickness of the film formed in this way is preferably 5 to 300 nm, more preferably 10 to 200 nm.
上述步驟(1)及(2)形成之塗膜可直接作為液晶配向膜使用,但也可對於該塗膜施以配向能力賦予處理。配向能力賦予處理可列舉將塗膜以捲繞了由例如尼龍、縲縈、棉等纖維構成之布的輥沿一定方向摩擦的摩擦處理、對於塗膜照射偏光或非偏光之放射線之光配向處理等。The coating film formed in the above steps (1) and (2) can be directly used as a liquid crystal alignment film, but the coating film can also be subjected to an alignment ability imparting treatment. Alignment-imparting treatment includes rubbing treatment in which the coated film is rubbed in a certain direction with a roll wound with a cloth made of fibers such as nylon, rayon, and cotton, and photo-alignment treatment in which the coated film is irradiated with polarized or non-polarized radiation. wait.
光配向處理中,對於塗膜照射之放射線,例如可使用含有波長150~800nm之光之紫外線及可見光線。放射線為偏光時,可為直線偏光也可為部分偏光。又,使用之放射線為直線偏光或部分偏光時,照射可從垂直基板表面的方向進行,也可從斜方向進行,或也可將它們組合進行。照射非偏光之放射線時,照射的方向為斜方向。In the photo-alignment treatment, for example, ultraviolet rays and visible rays including light with a wavelength of 150 to 800 nm can be used for the radiation irradiated to the coating film. When the radiation is polarized, it may be linearly polarized or partially polarized. Also, when the radiation used is linearly polarized or partially polarized, irradiation may be performed from a direction perpendicular to the substrate surface, or from an oblique direction, or a combination thereof. When irradiating non-polarized radiation, the direction of irradiation is oblique.
(3)在上述一對基板之間形成液晶層而製作液晶胞 (3-1)製造VA方式之液晶顯示元件時 準備2片如上述在2片基板中之至少一片形成了本發明之液晶配向膜之基板,在對向配置之2片基板間配置液晶。具體而言,可列舉以下2種方法。第一方法,係自以往已知之方法。首先,將各自的液晶配向膜面對的方式,隔著間隙(晶胞隙)將2片基板予以對向配置。然後,將2片基板的周邊部彼此使用密封劑予以貼合,對於由基板表面及密封劑區隔出的晶胞隙內注入填充液晶組成物而和膜面接觸後,將注入孔予以密封。 上述液晶組成物無特殊限制,可使用含有至少一種液晶化合物(液晶分子)且介電常數異向性為正或負之各種液晶組成物。又,以下也將介電常數異向性為正之液晶組成物稱為正型液晶,介電常數異向性為負之液晶組成物稱為負型液晶。 上述液晶組成物也可含有具有氟原子、羥基、胺基、含氟原子之基(例:三氟甲基)、氰基、烷基、烷氧基、烯基、異硫氰酸酯基、雜環、環烷、環烯、類固醇骨架、苯環、或萘環之液晶化合物,也可含有分子內具有2個以上之展現液晶性之剛直部位(液晶原骨架)之化合物(例如:剛直的二個聯苯結構、或聯三苯結構以烷基連結成的雙液晶原化合物等)。液晶組成物可為呈向列相之液晶組成物、呈層列相之液晶組成物、或呈膽固醇相之液晶組成物。 又,考量使液晶配向性更好的觀點,上述液晶組成物也可更添加添加物。如此的添加物例如:具有下列聚合性基之化合物等光聚合性單體;光學活性的化合物(例:默克(股)公司製之S-811等);抗氧化劑;紫外線吸收劑;色素;消泡劑;聚合起始劑;或聚合抑制劑等。 正型液晶可列舉默克公司製之ZLI-2293、ZLI-4792、MLC-2003、MLC-2041、MLC-3019或MLC-7081等。 負型液晶,例如默克公司製之MLC-6608、MLC-6609、MLC-6610、MLC-6882、MLC-6886、MLC-7026、MLC-7026-000、MLC-7026-100、或MLC-7029等。 又,PSA模式中,針對含有具聚合性基之化合物之液晶可列舉默克公司製之MLC-3023。 (3) Forming a liquid crystal layer between the above-mentioned pair of substrates to produce a liquid crystal cell (3-1) When manufacturing VA liquid crystal display elements Prepare two substrates on which the liquid crystal alignment film of the present invention is formed on at least one of the two substrates as described above, and arrange liquid crystals between the two facing substrates. Specifically, the following two methods can be mentioned. The first method is a method known from the past. First, two substrates are arranged facing each other with a gap (cell gap) therebetween so that the respective liquid crystal alignment films face each other. Then, the peripheral parts of the two substrates are bonded together using a sealant, and the liquid crystal composition is injected into the cell gap partitioned by the substrate surface and the sealant to make contact with the film surface, and then the injection hole is sealed. The above-mentioned liquid crystal composition is not particularly limited, and various liquid crystal compositions containing at least one liquid crystal compound (liquid crystal molecule) and having positive or negative dielectric anisotropy can be used. Hereinafter, a liquid crystal composition having a positive dielectric anisotropy is also referred to as a positive type liquid crystal, and a liquid crystal composition having a negative dielectric anisotropy is also referred to as a negative type liquid crystal. The above liquid crystal composition may also contain a fluorine atom, a hydroxyl group, an amino group, a group containing a fluorine atom (for example: trifluoromethyl group), a cyano group, an alkyl group, an alkoxy group, an alkenyl group, an isothiocyanate group, Liquid crystal compounds of heterocycles, cycloalkanes, cycloalkenes, steroid skeletons, benzene rings, or naphthalene rings may also contain compounds with two or more rigid sites (mesogen skeletons) exhibiting liquid crystallinity in the molecule (for example: rigid Two biphenyl structures, or a double mesogen compound formed by linking two terphenyl structures with an alkyl group, etc.). The liquid crystal composition may be a liquid crystal composition in a nematic phase, a liquid crystal composition in a smectic phase, or a liquid crystal composition in a cholesteric phase. In addition, from the viewpoint of improving the alignment of liquid crystals, additives may be further added to the above-mentioned liquid crystal composition. Such additives are, for example: photopolymerizable monomers such as compounds having the following polymerizable groups; optically active compounds (for example: S-811 manufactured by Merck Co., Ltd.); antioxidants; ultraviolet absorbers; pigments; defoaming agent; polymerization initiator; or polymerization inhibitor, etc. Examples of positive liquid crystals include ZLI-2293, ZLI-4792, MLC-2003, MLC-2041, MLC-3019, and MLC-7081 manufactured by Merck & Co., Ltd. Negative liquid crystal, such as MLC-6608, MLC-6609, MLC-6610, MLC-6882, MLC-6886, MLC-7026, MLC-7026-000, MLC-7026-100, or MLC-7029 manufactured by Merck wait. In addition, in the PSA mode, MLC-3023 manufactured by Merck is exemplified as a liquid crystal containing a compound having a polymerizable group.
又,第二方法係稱為ODF(One Drop Fill)方式之方法。於已形成液晶配向膜之2片基板中之一基板上之預定處塗佈例如紫外光硬化性之密封劑,再於液晶配向膜面上之預定數處滴加液晶組成物。之後以液晶配向膜面對的方式貼合另一基板,將液晶組成物推壓在基板之全面,使其接觸膜面。然後,對於基板全面照射紫外光,使密封劑硬化。Also, the second method is a method called ODF (One Drop Fill) method. Coat, for example, a UV-curable sealant on predetermined positions on one of the two substrates on which the liquid crystal alignment film has been formed, and then drop liquid crystal composition on predetermined positions on the surface of the liquid crystal alignment film. Then attach another substrate with the liquid crystal alignment film facing it, and push the liquid crystal composition onto the entire surface of the substrate so that it contacts the film surface. Then, the entire surface of the substrate is irradiated with ultraviolet light to harden the sealant.
於利用任一方法的情形,皆更加熱直到使用之液晶組成物採取等向相之溫度後,緩慢冷卻至室溫,以去除液晶填充時之流動配向較理想。 (3-2)製造PSA方式之液晶顯示元件時 將含有聚合性化合物之液晶組成物進行注入或滴加,除此以外和上述(3-1)同樣地實施。具有聚合性基之化合物,例如具有液晶原結構與2個以上之光聚合性基或熱聚合性基之化合物。具有聚合性基之化合物,例如:就液晶原結構而言,2個以上之芳香族基或脂肪族基連結成的結構,例如聯苯結構、聯三苯結構、萘環、從雙酚A取走了2個羥基之基、或該等結構擁有之氫原子之一部分或全部被氟原子取代之含氟原子之結構。具體的化合物可列舉4,4’-二甲基丙烯醯氧聯苯、或3-氟-1,1’-聯苯-4,4’-二基二甲基丙烯酸酯。 (3-3)使用含有具聚合性基之化合物之液晶配向劑在基板上形成塗膜時 和上述(3-1)同樣進行後,亦可採用經後述照射紫外線之步驟製造液晶顯示元件之方法。依此方法,和製造上述PSA方式之液晶顯示元件時同樣,能夠以少光照射量獲得響應速度優異之液晶顯示元件。具有聚合性基之化合物,亦可為上述具有聚合性基之化合物,其含量為相對於全部聚合物成分100質量份為0.1~30質量份較佳,更佳為1~20質量份。又,上述聚合性基可為液晶配向劑使用之聚合物所擁有,如此的聚合物,例如使用含有末端具有上述光聚合性基之二胺之二胺成分於反應而獲得之聚合物。 (4)對於液晶胞照光 以對於上述(3-2)或(3-3)獲得之一對基板所具有之導電膜間施加電壓之狀態,對於液晶胞照光。在此施加之電壓,例如可設為5~50V之直流或交流。又,照射之光,可使用例如含有波長150~800nm之光之紫外線及可見光線,但宜含有波長300~400nm之光之紫外線較佳。照射光之光源,例如低壓水銀燈、高壓水銀燈、氘燈、金屬鹵化物燈、氬氣共振燈、氙燈、準分子雷射等。光之照射量較佳為1,000~200,000J/m 2,更佳為1,000~100,000J/m 2。 In the case of using either method, heat it up until the liquid crystal composition used takes the temperature of the isotropic phase, and then cool slowly to room temperature to remove the flow alignment when the liquid crystal is filled. (3-2) The liquid crystal composition containing a polymerizable compound is injected or dripped at the time of manufacture of the liquid crystal display element of a PSA system, and it carries out similarly to said (3-1). A compound having a polymerizable group, for example, a compound having a mesogen structure and two or more photopolymerizable groups or thermal polymerizable groups. Compounds with polymeric groups, for example: in terms of mesogen structure, structures formed by linking two or more aromatic groups or aliphatic groups, such as biphenyl structure, terphenyl structure, naphthalene ring, bisphenol A A fluorine atom-containing structure in which two hydroxyl groups are removed, or a part or all of the hydrogen atoms possessed by such structures are replaced by fluorine atoms. Specific compounds include 4,4'-dimethacryloxybiphenyl and 3-fluoro-1,1'-biphenyl-4,4'-diyl dimethacrylate. (3-3) When using a liquid crystal alignment agent containing a compound having a polymerizable group to form a coating film on the substrate, it is also possible to use the method of manufacturing a liquid crystal display element through the step of irradiating ultraviolet rays described later in the same manner as in (3-1) above. . According to this method, a liquid crystal display element excellent in response speed can be obtained with a small amount of light irradiation, as in the case of manufacturing the above-mentioned PSA type liquid crystal display element. The compound having a polymerizable group may be the above-mentioned compound having a polymerizable group, and its content is preferably 0.1 to 30 parts by mass, more preferably 1 to 20 parts by mass, based on 100 parts by mass of the entire polymer component. In addition, the above-mentioned polymerizable group may be possessed by the polymer used in the liquid crystal alignment agent. Such a polymer is, for example, a polymer obtained by reacting a diamine component containing a diamine having the above-mentioned photopolymerizable group at the end. (4) Irradiation of the liquid crystal cell The liquid crystal cell is irradiated with light in a state where a voltage is applied between the conductive films of the pair of substrates obtained in the above (3-2) or (3-3). The voltage to be applied here can be, for example, a direct current or alternating current of 5 to 50V. Also, as the light to be irradiated, for example, ultraviolet rays and visible rays including light with a wavelength of 150 to 800 nm can be used, but ultraviolet light with a wavelength of 300 to 400 nm is preferably used. Light sources for irradiating light, such as low-pressure mercury lamps, high-pressure mercury lamps, deuterium lamps, metal halide lamps, argon resonance lamps, xenon lamps, excimer lasers, etc. The amount of light irradiation is preferably from 1,000 to 200,000 J/m 2 , more preferably from 1,000 to 100,000 J/m 2 .
並且,藉由在液晶胞之外側表面貼合偏光板,可獲得液晶顯示元件。貼合在液晶胞外側表面的偏光板,可列舉: 以乙酸纖維素保護膜夾持邊將聚乙烯醇延伸配向邊使其吸收碘而得之稱為「H膜」之偏光薄膜而成的偏光板或H膜本身構成的偏光板。Furthermore, a liquid crystal display element can be obtained by attaching a polarizing plate to the outer surface of the liquid crystal cell. The polarizing plate attached to the outer surface of the liquid crystal cell includes: Polarizing film made of polarizing film called "H film" obtained by sandwiching cellulose acetate protective film while stretching and aligning polyvinyl alcohol to absorb iodine Polarizing plate composed of plate or H film itself.
本發明之液晶顯示元件可有效地適用於各種裝置,例如:鐘錶、可攜式遊戲機、文字處理機、筆記型個人電腦、導航系統、攝錄影機、PDA、數位相機、行動電話、智慧手機、各種螢幕、液晶電視、資訊顯示器等各種顯示裝置。又,上述液晶配向劑也可使用在相位差薄膜用之液晶配向膜、掃描天線、液晶陣列天線用之液晶配向膜或透射散射型之液晶調光元件用之液晶配向膜、或此等以外之用途,例如彩色濾光片之保護膜、可撓性顯示器之閘絕緣膜、基板材料。 [實施例] The liquid crystal display device of the present invention can be effectively applied to various devices, such as: clocks, portable game machines, word processors, notebook personal computers, navigation systems, camcorders, PDAs, digital cameras, mobile phones, smart phones Various display devices such as mobile phones, various monitors, LCD TVs, and information displays. In addition, the above-mentioned liquid crystal alignment agent can also be used in the liquid crystal alignment film for the phase difference film, the liquid crystal alignment film for the scanning antenna, the liquid crystal array antenna, or the liquid crystal alignment film for the transmission and scattering type liquid crystal dimming element, or other than these Applications, such as protective films for color filters, gate insulating films for flexible displays, and substrate materials. [Example]
以下舉實施例對於本發明更詳細說明,但本發明不限於此等而解釋。使用之化合物之簡稱及各物性之測定方法如下。 (有機溶劑) NMP:N-甲基-2-吡咯烷酮 BCS:丁基賽珞蘇(乙二醇單丁醚) (四羧酸二酐) The following examples are given to describe the present invention in more detail, but the present invention is not limited thereto. The abbreviations of the compounds used and the measurement methods of the respective physical properties are as follows. (Organic solvents) NMP: N-methyl-2-pyrrolidone BCS: butyl cellosu (ethylene glycol monobutyl ether) (tetracarboxylic dianhydride)
[化10] [chemical 10]
(二胺)(diamine)
[化11] [chemical 11]
(添加劑)(additive)
[化12] [chemical 12]
<黏度之測定> 使用E型黏度計TVE-22H(東機產業公司製),使用樣本量1.1mL(毫升)、錐形轉子TE-1(1°34’、R24),於溫度25℃測定。 <分子量之測定> 利用下列常溫GPC(凝膠滲透層析)裝置測定,並就聚乙二醇、聚環氧乙烷換算值算出Mn及Mw。 <Measurement of Viscosity> Using an E-type viscometer TVE-22H (manufactured by Toki Sangyo Co., Ltd.), using a sample volume of 1.1 mL (milliliters) and a conical rotor TE-1 (1°34', R24), it was measured at a temperature of 25°C. <Determination of Molecular Weight> Mn and Mw were calculated using the following room temperature GPC (Gel Permeation Chromatography) apparatus, and calculated values in terms of polyethylene glycol and polyethylene oxide.
GPC裝置:GPC-101(昭和電工公司製)、管柱:GPC KD-803、GPC KD-805(昭和電工公司製)之串聯、管柱溫度:50℃、溶離液:N,N-二甲基甲醯胺(添加劑為溴化鋰一水合物(LiBr・H2O)30mmol/L、磷酸無水結晶(正磷酸)30mmol/L、四氫呋喃(THF)10mL/L)、流速:1.0mL/分 檢量線製作用標準樣本:TSK 標準聚環氧乙烷(分子量;約900,000、150,000、100,000及30,000)(東曹公司製)及聚乙二醇(分子量;約12,000、4,000及1,000)(Polymer Laboratory Corporation製)。 [聚醯胺酸之合成] <合成例1> 於附設攪拌裝置及氮氣導入管之50mL四口燒瓶中加入DA-1(2.26g、8.00mmol)、DA-4(1.45g、6.00mmol)、DA-5(2.46g、6.00mmol)及NMP(24.7g),邊送入氮氣邊於室溫攪拌而使其溶解。之後加入CA-1(2.63g、13.4mmol)及NMP(10.0g),於室溫攪拌2小時。之後加入CA-2(1.31g、6.00mmol)及NMP(5.20g),於室溫攪拌20小時,以獲得固體成分濃度20質量%之聚醯胺酸(PAA-1)之溶液(黏度:714mPa・s)。此聚醯胺酸之Mn為11,329、Mw為27,338。 <合成例2> 於附設攪拌裝置及氮氣導入管之50mL四口燒瓶中加入DA-2(2.48g、8.00mmol)、DA-4(1.45g、6.00mmol)、DA-5(2.46g、6.00mmol)及NMP(25.6g),邊送入氮氣邊於室溫攪拌而使其溶解。之後加入CA-1(2.51g、12.8mmol)及NMP(10.0g),於室溫攪拌2小時。之後加入CA-2(1.31g、6.00mmol)及NMP(5.20g),於室溫攪拌20小時以獲得固體成分濃度20質量%之聚醯胺酸(PAA-2)之溶液(黏度:839mPa・s)。此聚醯胺酸之Mn為14,348、Mw為37,799。 <合成例3> 於附設攪拌裝置及氮氣導入管之50mL四口燒瓶中加入DA-3(1.98g、10.0mmol)、DA-4(1.82g、7.50mmol)、DA-5(3.08g、7.50mmol)及NMP(27.5g),邊送入氮氣邊於室溫攪拌而使其溶解。之後加入CA-1(3.14g、16.0mmol)及NMP(12.6g),於室溫攪拌2小時。之後加入CA-2(1.64g、7.50mmol)及NMP(6.50g),於室溫攪拌20小時以獲得固體成分濃度20質量%之聚醯胺酸(PAA-3)之溶液(黏度:750mPa・s)。此聚醯胺酸之Mn為9,793、Mw為22,690。 GPC device: GPC-101 (manufactured by Showa Denko Co., Ltd.), column: GPC KD-803, GPC KD-805 (manufactured by Showa Denko Co., Ltd.) in series, column temperature: 50°C, eluent: N,N-Dimethicone Methyl formamide (additives are lithium bromide monohydrate (LiBr・H2O) 30mmol/L, phosphoric acid anhydrous crystal (orthophosphoric acid) 30mmol/L, tetrahydrofuran (THF) 10mL/L), flow rate: 1.0mL/min Standard samples for calibration line production: TSK standard polyethylene oxide (molecular weight; about 900,000, 150,000, 100,000, and 30,000) (manufactured by Tosoh Corporation) and polyethylene glycol (molecular weight; about 12,000, 4,000, and 1,000) (Polymer Laboratory Corporation). [Synthesis of polyamide acid] <Synthesis Example 1> Add DA-1 (2.26g, 8.00mmol), DA-4 (1.45g, 6.00mmol), DA-5 (2.46g, 6.00mmol) and NMP ( 24.7 g), and was dissolved by stirring at room temperature while feeding nitrogen gas. Then, CA-1 (2.63 g, 13.4 mmol) and NMP (10.0 g) were added, and it stirred at room temperature for 2 hours. Then add CA-2 (1.31g, 6.00mmol) and NMP (5.20g), and stir at room temperature for 20 hours to obtain a solution of polyamic acid (PAA-1) with a solid content concentration of 20% by mass (viscosity: 714mPa・s). The Mn of this polyamide acid is 11,329, and the Mw is 27,338. <Synthesis Example 2> Add DA-2 (2.48g, 8.00mmol), DA-4 (1.45g, 6.00mmol), DA-5 (2.46g, 6.00mmol) and NMP ( 25.6 g), and was dissolved by stirring at room temperature while feeding nitrogen gas. Then, CA-1 (2.51 g, 12.8 mmol) and NMP (10.0 g) were added, and it stirred at room temperature for 2 hours. Then add CA-2 (1.31g, 6.00mmol) and NMP (5.20g), and stir at room temperature for 20 hours to obtain a solution of polyamic acid (PAA-2) with a solid content concentration of 20% by mass (viscosity: 839mPa· s). The Mn of this polyamide acid is 14,348, and the Mw is 37,799. <Synthesis Example 3> Add DA-3 (1.98g, 10.0mmol), DA-4 (1.82g, 7.50mmol), DA-5 (3.08g, 7.50mmol) and NMP ( 27.5 g), and was dissolved by stirring at room temperature while feeding nitrogen gas. Then, CA-1 (3.14 g, 16.0 mmol) and NMP (12.6 g) were added, and it stirred at room temperature for 2 hours. Then add CA-2 (1.64g, 7.50mmol) and NMP (6.50g), and stir at room temperature for 20 hours to obtain a solution of polyamic acid (PAA-3) with a solid content concentration of 20% by mass (viscosity: 750mPa· s). The Mn of this polyamide acid was 9,793, and the Mw was 22,690.
上述合成例1~3使用之四羧酸成分及二胺成分之種類及量示於表1。表中,各成分之數值,係各成分相對於二胺成分之合計量100莫耳份之莫耳份。Table 1 shows the kinds and amounts of tetracarboxylic acid components and diamine components used in Synthesis Examples 1 to 3 above. In the table, the numerical value of each component is the mole part of each component relative to the total amount of 100 mole parts of the diamine component.
[表1]
[液晶配向劑之製備] <實施例1> 於合成例1獲得之聚合物之溶液(6.00g)中加入NMP(4.80g)及BCS(8.00g),再加入AD-1(10質量%NMP溶液、1.20g),於室溫攪拌2小時,以獲得液晶配向劑AL-1。上述液晶配向劑AL-1未觀察到混濁、析出等異常,確認樹脂成分已均勻溶解。 <實施例2、比較例1> 使用之聚醯胺酸溶液依表2所示變更,除此以外和上述實施例1同樣實施,以獲得實施例2之液晶配向劑AL-2、及比較例1之液晶配向劑AL-C1。上述液晶配向劑AL-2及AL-C1未觀察到混濁、析出等異常,確認樹脂成分已均勻地溶解。 [Preparation of liquid crystal alignment agent] <Example 1> Add NMP (4.80g) and BCS (8.00g) to the polymer solution (6.00g) obtained in Synthesis Example 1, then add AD-1 (10% by mass NMP solution, 1.20g), and stir at room temperature for 2 hours to obtain liquid crystal alignment agent AL-1. Abnormalities such as turbidity and precipitation were not observed in the above-mentioned liquid crystal alignment agent AL-1, and it was confirmed that the resin component was uniformly dissolved. <Example 2, Comparative Example 1> The polyamic acid solution used was changed as shown in Table 2, except that it was carried out in the same manner as in Example 1 to obtain the liquid crystal alignment agent AL-2 of Example 2 and the liquid crystal alignment agent AL-C1 of Comparative Example 1. Abnormalities such as turbidity and precipitation were not observed in the above-mentioned liquid crystal alignment agents AL-2 and AL-C1, and it was confirmed that the resin components were uniformly dissolved.
[表2]
[透射率之測定] 將上述實施例1~2及比較例1獲得之液晶配向劑AL-1~AL-2及AL-C1分別旋塗於石英基板,於70℃之熱板煅燒90秒後,以230℃之紅外線加熱爐進行20分鐘煅燒,製作膜厚100nm之附液晶配向劑之石英基板。使此附液晶配向膜之基板為內側,使用另一片石英基板,為了防止光干涉而夾持接觸液(島津器件製造公司製)。對其以島津製作所公司製UV-3600,於溫度:25℃、掃描波長:380~800nm進行測定。此時,使用以未經塗膜之2片石英基板夾持接觸液作為對照。評價係使用波長380nm之透射率。結果示於表3。 [Measurement of transmittance] Spin-coat the liquid crystal alignment agents AL-1-AL-2 and AL-C1 obtained in the above-mentioned Examples 1-2 and Comparative Example 1 on a quartz substrate, and calcinate on a hot plate at 70°C for 90 seconds, then use infrared rays at 230°C Calcined in a heating furnace for 20 minutes to produce a quartz substrate with a film thickness of 100 nm and a liquid crystal alignment agent. This substrate with a liquid crystal alignment film was placed inside, and another quartz substrate was used to sandwich a contact liquid (manufactured by Shimadzu Device Manufacturing Co., Ltd.) in order to prevent light interference. This was measured with UV-3600 manufactured by Shimadzu Corporation at a temperature of 25° C. and a scanning wavelength of 380 to 800 nm. At this time, the contact solution was sandwiched between two quartz substrates without coating as a control. The evaluation uses the transmittance at a wavelength of 380nm. The results are shown in Table 3.
[表3]
如表1,由使用了含特定二胺DA-1~DA-2之二胺成分之液晶配向劑獲得之實施例1~2之液晶配向膜,相較於使用了由不含特定二胺之二胺成分之液晶配向劑獲得之比較例1之液晶配向膜,顯示較高透射率。又,透射率1%之差距,在該技術領域係有顯著差異。 [電壓保持率評價用之液晶胞之製作] 使用上述實施例1~2及比較例1獲得之液晶配向劑AL-1~AL-2及AL-C1,依下列所示之程序實施液晶胞之製作。將液晶配向劑分別旋塗在附ITO電極之玻璃基板,於70℃之熱板上乾燥90秒後,以230℃之紅外線加熱爐進行20分鐘煅燒,形成膜厚100nm之液晶配向膜。準備2片附該液晶配向膜之基板,於其中一片基板之液晶配向膜上塗佈直徑4μm之珠粒間隔件(日揮觸媒化成公司製,真絲球、SW-D1),保留液晶注入口而在周圍印刷熱硬化性密封劑(三井化學公司製,XN-1500T)。然後,將另一片基板之已形成液晶配向膜之側之面作為內側,和先前的基板貼合後,使密封劑硬化而製作空胞。於此空胞中以減壓注入法注入液晶MLC-3023(默克公司製),製作成液晶胞。然後於此液晶胞中施加15V之DC電壓之狀態,從液晶胞之外側照射10J/cm 2已通過波長325nm以下之截止濾波器之紫外線。又,紫外線之照度係使用ORC公司製UV-MO3A測定。之後,為了使液晶胞中殘存之未反應之聚合性化合物失活,以未施加電壓之狀態使用TOSHBA LIGHTECH公司製UV-FL照射裝置,照射紫外線(UV燈:FLR40SUV32/A-1)30分鐘。 [電壓保持率之評價] 使用紫外線照射後之電壓保持率評價用之液晶胞來測定電壓保持率。於60℃之熱風循環烘箱中施加1V電壓60μsec,之後測定1667msec後之電壓,計算能保持多少電壓並定義為電壓保持率。電壓保持率之測定,係使用TOYO TECHNICA公司製之VHR-1。值越高越良好。結果示於表4。 As shown in Table 1, the liquid crystal alignment films of Examples 1 to 2 obtained from liquid crystal alignment agents using diamine components containing specific diamines DA-1 to DA-2 are compared to those obtained from liquid crystal alignment films that do not contain specific diamines. The liquid crystal alignment film of Comparative Example 1 obtained from the liquid crystal alignment agent composed of diamine exhibited higher transmittance. Also, a difference of 1% in transmittance is a significant difference in this technical field. [Preparation of liquid crystal cells for evaluation of voltage retention] Using the liquid crystal alignment agents AL-1 to AL-2 and AL-C1 obtained in Examples 1 to 2 and Comparative Example 1 above, the liquid crystal cells were prepared according to the procedure shown below. make. The liquid crystal alignment agent was spin-coated on the glass substrate with ITO electrodes, dried on a hot plate at 70°C for 90 seconds, and then calcined in an infrared heating furnace at 230°C for 20 minutes to form a liquid crystal alignment film with a film thickness of 100nm. Prepare 2 substrates with the liquid crystal alignment film, and coat a bead spacer with a diameter of 4 μm (manufactured by Nikki Catalyst Chemicals Co., Ltd., silk ball, SW-D1) on the liquid crystal alignment film of one of the substrates, and keep the liquid crystal injection port. A thermosetting sealant (manufactured by Mitsui Chemicals, Inc., XN-1500T) was printed on the periphery. Then, the surface of the other substrate on which the liquid crystal alignment film has been formed is set as the inner side, and after being bonded to the previous substrate, the sealant is hardened to form void cells. Liquid crystal MLC-3023 (manufactured by Merck & Co.) was injected into the ghost cell by a reduced-pressure injection method to produce a liquid crystal cell. Then, with a DC voltage of 15V applied to the liquid crystal cell, 10J/cm 2 of ultraviolet light that has passed through a cut-off filter with a wavelength of 325nm or less is irradiated from the outside of the liquid crystal cell. In addition, the illuminance of ultraviolet rays was measured using UV-MO3A manufactured by ORC Corporation. Afterwards, in order to inactivate the unreacted polymerizable compound remaining in the liquid crystal cell, ultraviolet light (UV lamp: FLR40SUV32/A-1) was irradiated for 30 minutes using a UV-FL irradiation device manufactured by TOSHBA LIGHTECH Co., Ltd. without applying voltage. [Evaluation of Voltage Holding Rate] The voltage holding rate was measured using a liquid crystal cell for evaluating the voltage holding rate after ultraviolet irradiation. Apply a voltage of 1V for 60μsec in a hot air circulation oven at 60°C, then measure the voltage after 1667msec, calculate how much voltage can be maintained and define it as the voltage retention rate. The measurement of the voltage retention ratio used VHR-1 manufactured by TOYO TECHNICA. Higher values are better. The results are shown in Table 4.
[表4]
如表4所示,使用了實施例1~2之液晶配向劑之液晶配向膜,保持了良好的電壓保持率。As shown in Table 4, the liquid crystal alignment films using the liquid crystal alignment agents of Examples 1-2 maintained good voltage retention.
又,在此引用2021年8月6日提申的日本專利出願2021-129553號的說明書、申請專利範圍、圖式及摘要的全部內容,並援引作為本發明之說明書之揭示內容。In addition, the entire contents of the specification, claims, drawings, and abstract of Japanese Patent Application No. 2021-129553 filed on August 6, 2021 are cited here, and are cited as the disclosure content of the specification of the present invention.
Claims (17)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021129553 | 2021-08-06 | ||
JP2021-129553 | 2021-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202321428A true TW202321428A (en) | 2023-06-01 |
Family
ID=85155678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW111129272A TW202321428A (en) | 2021-08-06 | 2022-08-04 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPWO2023013622A1 (en) |
CN (1) | CN118056157A (en) |
TW (1) | TW202321428A (en) |
WO (1) | WO2023013622A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI859005B (en) | 2023-11-23 | 2024-10-11 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007241249A (en) * | 2006-02-07 | 2007-09-20 | Jsr Corp | Vertically aligned liquid crystal alignment agent and vertically aligned liquid crystal display element |
CN102947753B (en) * | 2010-04-22 | 2015-09-02 | 日产化学工业株式会社 | Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells |
JP6187473B2 (en) * | 2012-10-31 | 2017-08-30 | Jnc株式会社 | Liquid crystal display element and manufacturing method thereof |
TWI740043B (en) * | 2018-05-18 | 2021-09-21 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
-
2022
- 2022-08-02 JP JP2023540353A patent/JPWO2023013622A1/ja active Pending
- 2022-08-02 CN CN202280066975.7A patent/CN118056157A/en active Pending
- 2022-08-02 WO PCT/JP2022/029592 patent/WO2023013622A1/en active Application Filing
- 2022-08-04 TW TW111129272A patent/TW202321428A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI859005B (en) | 2023-11-23 | 2024-10-11 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
Also Published As
Publication number | Publication date |
---|---|
JPWO2023013622A1 (en) | 2023-02-09 |
CN118056157A (en) | 2024-05-17 |
WO2023013622A1 (en) | 2023-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023286733A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, method for producing liquid crystal display element, and liquid crystal display element | |
WO2022270287A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
CN106398721B (en) | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, method for producing liquid crystal alignment film, polymer, and diamine | |
WO2022234820A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TW202237800A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TW202246468A (en) | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, diamine, and polymer | |
TW202321428A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TWI830451B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
WO2023032753A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP7497782B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP7505643B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
WO2024122359A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
WO2023286735A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element production method, and liquid crystal display element | |
WO2022250007A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, diamine, and polymer | |
WO2023032784A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
WO2023068085A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, and compound | |
TW202405141A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TW202328410A (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
TW202309251A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TW202436599A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
WO2023074392A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
WO2024203156A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
TW202311505A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal element | |
TW202436600A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
WO2023068084A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, compound and polymer |